Profiles

Andrew Palmer

UTAS Home › Professor Andrew Palmer

Andrew Palmer

New Star Professor of Medical Research, Founding Chair, Health Economics Research Unit
Menzies Institute for Medical Research

Room 353b-02 (Level 3) , Medical Science 2

+61 3 6226 7729 (phone)

Andrew.Palmer@utas.edu.au

Prof Andrew Palmer is a New Star Professor of Medical Research and the Head of the Health Economics Research Unit at Menzies, working in the field of health economics since 1994. He is a leader in the subject of health economics in chronic diseases, has conducted research and published extensively in many disease areas including aged care/dementia, diabetes, multiple sclerosis, kidney disease, hypertension, dyslipidaemia, osteoporosis, alcoholism, growth hormone deficiency, rheumatoid arthritis, cardiovascular disease and oncology.

As well as being the Associate Editor (Health Economics) of Diabetic Medicine, he is the 2013-15 International Diabetes Federation (IDF) Chairman of the Task Force on Health Economics, the Co-founder/current Steering Committee member of the Mount Hood Modelling Diabetes Group, a Member of the 2013-15 Heart Foundation Future Fellows Selection Committee, member of the 2013-15 National Diabetes Strategy Group reporting to the Federal Minister for Health, Member of the Diabetes Australia Health Economics Expert Reference Group, and was an American Diabetes Association panel member for the development of diabetes health economics modelling guidelines.

Biography

Prof Palmer studied medicine at the University of Tasmania, after which he worked at the Launceston General Hospital, then as a general practitioner in Sydney. In 1994 he moved to Switzerland, where he was researcher and Medical Director of the Institute for Medical Informatics and Biostatistics (IMIB) from 1994 until 2000. CI Palmer co-founded CORE, Center for Outcomes Research, in Basel, Switzerland in July 2000 and was Medical Director and CEO until 2005. He was named by the International Society for Pharmacoeconomics and Outcomes Research as one of the top 10 most influential people in health economics in 2005.

Career summary

Qualifications

  • BmedSci, University of Tasmania, Australia, 1984
  • MBBS, University of Tasmania, Australia, 1987

Languages (other than English)

  • German (fluent written and oral)

Memberships

Professional practice

  • International Diabetes Federation (IDF) Chairman of the Task Force on Health Economics, 2013-15
  • National Diabetes Strategy Group reporting to the Federal Minister for Health, 2014-15

Committee associations

  • Heart Foundation Future Fellows Selection Committee, 2013-2015

Administrative expertise

  • Founding chair and head of the Department of Health Economics, Menzies Institute for Medical Research, University of Tasmania
  • Co-founder and current Steering Committee member of the Mount Hood Modelling Diabetes Group, the world's leading international diabetes health economics development and validation group

Teaching

Decision analysis, Modelling, Health economics, Diabetes, TreeAge software

Teaching expertise

  • Introduction to health economics
  • Practical methods in health economics
  • TreeAge Decision Analysis Software

Research Appointments

  • Member of the 2013, 2014, 2015 Heart Foundation Future Fellows Selection Committee
  • Member of the 2013-15 National Diabetes Strategy Group reporting to the Federal Minister for Health
  • Member of the Diabetes Australia Health Economics Expert Reference Group
  • Chairman, International Diabetes Federation, Task Force on Health Economics

View more on Professor Andrew Palmer in WARP

Expertise

  • Bicycle accident research
  • Horse racing industry health economics
  • Diabetes health economics
  • Workplace health promotion health economics
  • Haemochromatosis health economics
  • Multiple sclerosis health economics
  • Obesity health economics
  • Bariatric surgery health economics
  • Osteoporosis health economics
  • Aged care health economics

Research Themes

Professor Palmer's research aligns with the university's research theme of Better Health. He has conducted research and published extensively in the area of health economics and the modelling of diabetes and diabetes prevention.

In addition to his work in the area of diabetes, CI Palmer has conducted research and published extensively in other disease areas including multiple sclerosis, nephropathy and renal failure, hypertension, dyslipidaemia, deep vein thrombosis and pulmonary embolism prevention, osteoporosis, alcoholism, growth hormone deficiency, rheumatoid arthritis, cardiovascular disease and oncology.

CI Palmer led the development of the CORE Diabetes Model, which has been used to inform reimbursement and policy decisions regarding diabetes interventions on an international scale. The CORE Diabetes Model is the most widely published diabetes health economics model, and has been used in over 30 reimbursement submissions for pharmaceutical agents and devices worldwide. The methodology applied by CI Palmer's team has been used as the basis for international recommendations for guidelines in diabetes modelling.

CI Palmer co-founded, has chaired and been an active member of the Steering Committee of the Mount Hood Modelling Group, committed to the increased accuracy, validity and usefulness of complex diabetes models throughout the world. He was part of the American Diabetes Association Panel for developing guidelines/recommendations on the development of models of diabetes. The data generated from the MS prevalence and cost of illness study was used by Australia's leading MS advocacy group, MS Research Australia, to lobby the federal government for implementation of the Disability Insurance Scheme (in the meantime this has been passed with bipartisan support in the Federal Parliament).

Awards

  • ISPOR Asia-Pacific 2014 Best Research Poster Presentation
  • International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Asia-Pacific 2010: Best Research Podium Presentation
  • ISPOR Asia-Pacific 2010: Best Research Podium Presentation
  • Named by International Society for Pharmacoeconomics and Outcomes Research (ISPOR) as 'one of the 10 most influential people in the field of health economics and outcomes research in 2005'
  • ISPOR Europe 2005: Best Contributed Podium Presentation (first author)
  • ISPOR Europe 2004: Best Contributed Podium Presentation (co-author)
  • Deutsche Medizinische Wochenschrift (German Medical Journal) Walter Siegenthaler Preis 2001 (DMW Journal Article of the Year, 2001)

Current projects

  1. Bariatric surgery in Tasmania: investigating health service use, costs, patient outcomes and policy options
  2. Development of new diabetes health outcomes model
  3. Development of new osteoporosis health outcomes model
  4. Diabetes - Cost effectiveness of the COACH program in Tasmania, in association with Diabetes Tasmania
  5. Diabetes - Mount Hood Challenge Conference Series
  6. Haemochromatosis in Australia: a Cost of Illness Study
  7. Health Economics of Haemochromatosis
  8. Multiple Sclerosis - Development of an Australian Gold Standard Health Economics Model in conjunction with MS Research Australia
  9. Tasmanian Cycling Habits Accident Risk and Costs

Fields of Research

  • Health economics (380108)
  • Health services and systems (420399)
  • Epidemiology (420299)
  • Central nervous system (320903)
  • Respiratory diseases (320103)
  • Neurology and neuromuscular diseases (320905)
  • Aged health care (420301)
  • Cardiology (incl. cardiovascular diseases) (320101)
  • Rheumatology and arthritis (320223)
  • Health promotion (420603)
  • Health informatics and information systems (420308)
  • Endocrinology (320208)
  • Health and community services (420305)
  • Public health (420699)
  • Health care administration (420306)
  • Primary health care (420319)
  • Residential client care (420320)
  • Paediatrics (321399)
  • Clinical sciences (320299)
  • Gastroenterology and hepatology (320209)
  • Traditional, complementary and integrative medicine (420899)
  • Cardiovascular medicine and haematology (320199)
  • Nephrology and urology (320214)
  • Environmental epidemiology (420203)
  • Mental health services (420313)
  • Aged care nursing (420502)
  • Aboriginal and Torres Strait Islander public health and wellbeing (450417)
  • Disease surveillance (420202)
  • Preventative health care (420605)
  • Surgery (320226)
  • Autonomic nervous system (320901)
  • Health policy (440706)
  • Occupational and workplace health and safety (350505)
  • Health psychology (520304)
  • Behavioural epidemiology (420201)
  • Paramedicine (320219)
  • Medicine, nursing and health curriculum and pedagogy (390110)
  • Medical genetics (excl. cancer genetics) (320213)
  • Cancer diagnosis (321102)
  • Climate change processes (370201)
  • Cancer genetics (321103)
  • Infectious diseases (320211)
  • Sports medicine (320225)
  • Exercise physiology (420702)
  • Medical biochemistry - amino acids and metabolites (320501)
  • Environment policy (440704)
  • Pain (320218)
  • Physiotherapy (420106)
  • Haematology (320102)
  • Social determinants of health (420606)
  • Geriatrics and gerontology (320210)
  • Ecosystem function (410203)
  • Health systems (420311)
  • Sociology (441099)
  • Applied sociology, program evaluation and social impact assessment (441001)
  • Epidemiological modelling (420205)
  • Anaesthesiology (320201)
  • Community and primary care (420503)
  • Nursing (420599)
  • Clinical pharmacy and pharmacy practice (321403)
  • Implementation science and evaluation (420312)
  • Architectural science and technology (330105)
  • Community child health (420601)
  • Aboriginal and Torres Strait Islander and disability (450401)
  • Rehabilitation (420109)
  • Educational technology and computing (390405)
  • Social epidemiology (420210)
  • Health equity (420602)
  • Allergy (320401)
  • Peripheral nervous system (320906)
  • General practice (420304)
  • Multimorbidity (420314)
  • Major global burdens of disease (420207)

Research Objectives

  • Evaluation of health and support services (200299)
  • Clinical health (200199)
  • Evaluation of health outcomes (200202)
  • Public health (excl. specific population health) (200499)
  • Health policy evaluation (200205)
  • Diagnosis of human diseases and conditions (200101)
  • Behaviour and health (200401)
  • Injury prevention and control (200408)
  • Health education and promotion (200203)
  • Health status (incl. wellbeing) (200407)
  • Treatment of human diseases and conditions (200105)
  • Specific population health (excl. Indigenous health) (200599)
  • Preventive medicine (200412)
  • Health related to ageing (200502)
  • Health system performance (incl. effectiveness of programs) (200206)
  • Other health (209999)
  • Disease distribution and transmission (incl. surveillance and response) (200404)
  • Provision of health and support services (200399)
  • Mental health (200409)
  • Nursing (200307)
  • Determinants of health (200201)
  • Other economic framework (159999)
  • Prevention of human diseases and conditions (200104)
  • Allied health therapies (excl. mental health services) (200301)
  • Overweight and obesity (200411)
  • Aboriginal and Torres Strait Islander health system performance (210303)
  • Occupational health (200507)
  • Human pain management (200103)
  • Health surveillance (200303)
  • Aboriginal and Torres Strait Islander health (210399)
  • Carbon and emissions trading (159901)
  • Aboriginal and Torres Strait Islander health status and outcomes (210302)
  • Inpatient hospital care (200304)
  • Nutrition (200410)
  • Disability and functional capacity (200403)
  • Primary care (200310)
  • Policies and development (160205)
  • Health protection and disaster response (200406)
  • Ageing and older people (230102)
  • Road safety (270311)
  • Network systems and services (220105)
  • Residential construction design (120205)
  • Rural and remote area health (200508)
  • Community health care (200302)
  • Mental health services (200305)
  • Information services (220399)
  • Palliative care (200309)

Publications

Prof Palmer has an H-Index of 25 (Scopus January 31, 2014), over 100 PubMed-listed publications; 1,916 citations; article with highest number of citations=174; 19 articles cited more than 30 times.

He has been a reviewer for a number of major international journals and societies, including American Journal of Kidney Disease, Annals of Internal Medicine, Clinical Therapeutics, Current Medical Research and Opinion, Diabetes Care, Diabetes Obesity and Metabolism, Diabetic Medicine, Diabetologia, European Journal of Health Economics, Expert Opinions in Pharmacology, International Society for Pharmacoeconomics and Outcomes Research, Journal of the American Medical Association (JAMA), PharmacoEconomics, Swiss Medical Weekly and Value in Health. He has participated in numerous advisory boards and been a key member of several major medical and health economics workshops.

Total publications

296

Journal Article

(255 outputs)
YearCitationAltmetrics
2023Campbell JA, van der Mei I, Taylor BV, Palmer AJ, Henson GJ, et al., 'Using qualitative free-text data to investigate the lived experience of the COVID-19 pandemic for a large cohort of Australians with different multiple sclerosis related disability levels', Journal of Neurology, Neurosurgery and Psychiatry ISSN 0022-3050 (2023) [Refereed Article]

[eCite] [Details]

Co-authors: Campbell JA; van der Mei I; Taylor BV; Henson GJ; Laslett LL; Simpson-Yap S; Claflin SB

2023Wong AW, Sun H, Cox IA, Fisher JH, Khalil N, et al., 'Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease', PLoS One, 18, (3) pp. 1-10. ISSN 1932-6203 (2023) [Refereed Article]

DOI: 10.1371/journal.pone.0283110 [eCite] [Details]

Co-authors: Cox IA; de Graaff B; Walters EH

Tweet

2023Zheng Q, Otahal P, Cox IA, de Graaff B, Campbell JA, et al., 'The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A simulation study', Frontiers in Medicine, 10 pp. 1-12. ISSN 2296-858X (2023) [Refereed Article]

DOI: 10.3389/fmed.2023.1157706 [eCite] [Details]

Co-authors: Otahal P; Cox IA; de Graaff B; Campbell JA; Ahmad H; Walters EH

Tweet

2022Campbell JA, Ahmad H, Chen G, van der Mei I, Taylor B, et al., 'Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia', Quality of Life Research ISSN 0962-9343 (2022) [Refereed Article]

DOI: 10.1007/s11136-022-03214-y [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Campbell JA; Ahmad H; van der Mei I; Taylor B; Claflin S; Henson GJ; Laslett L; Hawkes K; Hurst C; Waugh H

Tweet

2022Claflin S, Campbell JA, Norman R, Mason DF, Kalincik T, et al., 'Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand', The European Journal of Health Economics Article ePub ahead of print. ISSN 1618-7598 (2022) [Refereed Article]

DOI: 10.1007/s10198-022-01518-x [eCite] [Details]

Co-authors: Claflin S; Campbell JA; Simpson-Yap S; Blizzard CL; van der Mei I; Henson GJ; Taylor BV

Tweet

2022Cox IA, Campbell J, de Graaff B, Otahal P, Corte TJ, et al., 'Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D', Quality of life research pp. 1-21. ISSN 1573-2649 (2022) [Refereed Article]

DOI: 10.1007/s11136-022-03205-z [eCite] [Details]

Co-authors: Cox IA; Campbell J; de Graaff B; Otahal P; Walters EH

Tweet

2022Dinh HTT, de Graaff B, Campbell JA, Jose MD, Burgess JR, et al., 'Incremental healthcare expenditure attributable to diabetes mellitus: a cost of illness study in Tasmania, Australia', Diabetic Medicine, 39, (6) Article e14817. ISSN 0742-3071 (2022) [Refereed Article]

DOI: 10.1111/dme.14817 [eCite] [Details]

Citations: Scopus - 1Web of Science - 2

Co-authors: Dinh HTT; de Graaff B; Campbell JA; Jose MD; Burgess JR; Saunder T; Kitsos A; Wiggins N

Tweet

2022Dinh NTT, Cox IA, de Graaff B, Campbell JA, Stokes B, et al., 'A comprehensive systematic review of data linkage publications on diabetes in Australia', Frontiers in Public Health, 10 Article 757987. ISSN 2296-2565 (2022) [Refereed Article]

DOI: 10.3389/fpubh.2022.757987 [eCite] [Details]

Co-authors: Dinh NTT; Cox IA; de Graaff B; Campbell JA; Stokes B

Tweet

2022Dinh NTT, Cox IA, de Graaff B, Campbell JA, Stokes B, et al., 'A comprehensive systematic review of data linkage publications on diabetes in Australia', Frontiers in Public Health, 10 pp. 1-13. ISSN 2296-2565 (2022) [Refereed Article]

DOI: 10.3389/fpubh.2022.757987 [eCite] [Details]

Co-authors: Dinh NTT; Cox IA; de Graaff B; Campbell JA; Stokes B

Tweet

2022Dinh NTT, de Graaff B, Campbell JA, Jose MD, Burgess J, et al., 'Costs of major complications in people with and without diabetes in Tasmania, Australia', Australian Health Review, 46, (6) pp. 667-678. ISSN 0156-5788 (2022) [Refereed Article]

DOI: 10.1071/AH22180 [eCite] [Details]

Co-authors: Dinh NTT; de Graaff B; Campbell JA; Jose MD; Burgess J; Saunder T; Kitsos A; Wiggins N

Tweet

2022Dinh NTT, de Graaff B, Campbell JA, Jose MD, Burgess J, et al., 'Incremental healthcare expenditure attributable to diabetes mellitus: A cost of illness study in Tasmania, Australia', Diabetic Medicine, 39, (6) pp. 1-10. ISSN 0742-3071 (2022) [Refereed Article]

DOI: 10.1111/dme.14817 [eCite] [Details]

Citations: Scopus - 1Web of Science - 2

Co-authors: Dinh NTT; de Graaff B; Campbell JA; Jose MD; Burgess J; Saunders T; Kitsos A; Wiggins N

Tweet

2022Henson GJ, Taylor BV, van der Mei I, Claflin SB, Simpson-Yap S, et al., 'Protocol for a systematic review and meta-analysis of minimal important differences for generic multiattribute utility instruments', BMJ Open, 12, (10) Article e062703. ISSN 2044-6055 (2022) [Refereed Article]

DOI: 10.1136/bmjopen-2022-062703 [eCite] [Details]

Co-authors: Henson GJ; Taylor BV; van der Mei I; Claflin SB; Xia Q; Antony B; Singh Ambrish; Campbell JA

Tweet

2022Jose KA, Sharman MJ, Stanesby O, Greaves S, Venn A, et al., 'Incentivising public transport use for physical activity gain: process evaluation of the COVID-19 disrupted trips4health randomised controlled trial', The International Journal of Behavioral Nutrition and Physical Activity, 19, (1) pp. 1-13. ISSN 1479-5868 (2022) [Refereed Article]

DOI: 10.1186/s12966-022-01394-x [eCite] [Details]

Co-authors: Jose KA; Sharman MJ; Stanesby O; Venn A; Blizzard L; Cleland V

Tweet

2022Nguyen ALT, Blizzard CL, Yee KC, Campbell JA, Palmer AJ, et al., 'Hospitalisation costs of primary liver cancer in Australia: evidence from a data-linkage study', Australian Health Review, 46, (4) pp. 463-470. ISSN 0156-5788 (2022) [Refereed Article]

DOI: 10.1071/AH21395 [eCite] [Details]

Co-authors: Nguyen ALT; Blizzard CL; Yee KC; Campbell JA; de Graaff B

Tweet

2022Nguyen ALT, Blizzard CL, Yee KC, Palmer AJ, de Graaff B, 'Survival of primary liver cancer for people from culturally and linguistically diverse backgrounds in Australia', Cancer Epidemiology, 81 Article 102252. ISSN 1877-7821 (2022) [Refereed Article]

DOI: 10.1016/j.canep.2022.102252 [eCite] [Details]

Co-authors: Nguyen ALT; Blizzard CL; Yee KC; de Graaff B

Tweet

2022Nguyen H, Yee KC, Braude M, Moldovan C, Cocker F, et al., 'Accuracy of coded cause of death data: a study based on primary liver cancer', Tasman Medical Journal, 4, (2) pp. 12-20. ISSN 2652-1881 (2022) [Refereed Article]

[eCite] [Details]

Co-authors: Nguyen H; Yee KC; Cocker F; de Graaff B

Tweet

2022Orji NC, Campbell JA, Wills K, Hensher M, Palmer AJ, et al., 'Prevalence of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) in Australian primary care patients: only part of the story?', BMC Public Health, 22 Article 1516. ISSN 1471-2458 (2022) [Refereed Article]

DOI: 10.1186/s12889-022-13929-9 [eCite] [Details]

Co-authors: Orji NC; Campbell JA; Wills K; Hensher M; de Graaff B

Tweet

2022Singh A, Aitken D, Moonaz S, Palmer AJ, Blizzard CL, et al., 'A Randomised Controlled Trial of YOGa and Strengthening Exercise for Knee OsteoArthritis: Protocol for a Comparative Effectiveness Trial (YOGA Trial)', Journal of Functional Morphology and Kinesiology, 7, (4) Article 84. ISSN 2411-5142 (2022) [Refereed Article]

DOI: 10.3390/jfmk7040084 [eCite] [Details]

Co-authors: Singh A; Aitken D; Blizzard CL; Ding C; Drummen SJ; Jones Graeme; Anthony B

Tweet

2022Xia Q, Campbell JA, Si L, Ahmad H, de Graaff B, et al., 'Healthcare resource utilisation and predictors for critical care unit admissions after primary bariatric surgery in an Australian public hospital setting: an exploratory study using a mixed-methods approach', Australian Health Review, 46, (1) pp. 42-51. ISSN 0156-5788 (2022) [Refereed Article]

DOI: 10.1071/AH21251 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Xia Q; Campbell JA; Ahmad H; de Graaff B

Tweet

2022Xu T, Jing Y, Guo X, Campbell JA, Ahmad H, et al., 'Maternal choices and preferences for screening strategies of gestational diabetes mellitus: an exploratory study using discrete choice experiment', Frontiers in Public Health, 10 Article 864482. ISSN 2296-2565 (2022) [Refereed Article]

DOI: 10.3389/fpubh.2022.864482 [eCite] [Details]

Co-authors: Campbell JA; Ahmad H; Xia Q

Tweet

2022Zheng Q, Cox IA, Campbell JA, Xia Q, Otahal P, et al., 'Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis', ERJ Open Research, 8, (1) Article 00591-2021. ISSN 2312-0541 (2022) [Refereed Article]

DOI: 10.1183/23120541.00591-2021 [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Co-authors: Cox IA; Campbell JA; Xia Q; Otahal P; de Graaff B; Walters EH

Tweet

2022Zheng Q, Cox IA, de Graaff B, Campbell JA, Corte TJ, et al., 'The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument', Quality of Life Research Article online ahead of print. ISSN 0962-9343 (2022) [Refereed Article]

DOI: 10.1007/s11136-022-03331-8 [eCite] [Details]

Co-authors: Cox IA; de Graaff B; Campbell JA; Ahmad H; Zhao T; Walters EH

Tweet

2021Ahmad H, van der Mei I, Taylor BVM, Zhao T, Xia Q, et al., 'Does health-related quality of life differ between people with relapse onset and progressive onset Multiple Sclerosis?', Multiple Sclerosis and Related Disorders, 54 pp. 1-8. ISSN 2211-0348 (2021) [Refereed Article]

DOI: 10.1016/j.msard.2021.103138 [eCite] [Details]

Co-authors: Ahmad H; van der Mei I; Taylor BVM; Zhao T; Xia Q

Tweet

2021Boateng GO, Lartey ST, Baiden P, Si L, Biritwum RB, et al., 'Measuring Hypertension Progression With Transition Probabilities: Estimates From the WHO SAGE Longitudinal Study', Frontiers in Public Health, 9 pp. 1-12. ISSN 2296-2565 (2021) [Refereed Article]

DOI: 10.3389/fpubh.2021.571110 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Co-authors: Magnussen CG

Tweet

2021Borchers-Arriagada N, Bowman DMJS, Price O, Palmer AJ, Samson S, et al., 'Smoke health costs and the calculus for wildfires fuel management: a modelling study', The Lancet Planetary Health, 5, (9) pp. e608-e619. ISSN 2542-5196 (2021) [Refereed Article]

DOI: 10.1016/S2542-5196(21)00198-4 [eCite] [Details]

Citations: Scopus - 9Web of Science - 8

Co-authors: Borchers-Arriagada N; Bowman DMJS; Johnston FH

Tweet

2021Borchers-Arriagada N, Jones P, Palmer AJ, Bereznicki B, Cooling N, et al., 'What are the health and socioeconomic impacts of allergic respiratory disease in Tasmania?', Australian Health Review pp. A-I. ISSN 0156-5788 (2021) [Refereed Article]

DOI: 10.1071/AH20200 [eCite] [Details]

Co-authors: Borchers-Arriagada N; Jones P; Bereznicki B; Cooling N; Johnston J

Tweet

2021Chen J, Ahmad H, Taylor B, Palmer AJ, van der Mei I, 'Impact of remoteness on patient outcomes for people with multiple sclerosis in Australia', Multiple Sclerosis and Related Disorders, 55 Article 103208. ISSN 2211-0348 (2021) [Refereed Article]

DOI: 10.1016/j.msard.2021.103208 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Ahmad H; Taylor B; van der Mei I

Tweet

2021Claflin S, Klekociuk S, Campbell JA, Bessing B, Palmer AJ, et al., 'Association between MS-related knowledge, health literacy, self-efficacy, resilience, and quality of life in a large cohort of MS community members: A cross-sectional study', Multiple Sclerosis and Related Disorders, 54 pp. 1-10. ISSN 2211-0348 (2021) [Refereed Article]

DOI: 10.1016/j.msard.2021.103158 [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Co-authors: Claflin S; Klekociuk S; Campbell JA; Bessing B; van der Mei IAF; Taylor BVM

Tweet

2021Claflin SB, Campbell JA, Mason DF, Kalincik T, Simpson-Yap S, et al., 'The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis', Multiple Sclerosis Article online ahead of publication. ISSN 1352-4585 (2021) [Refereed Article]

DOI: 10.1177/13524585211035948 [eCite] [Details]

Citations: Scopus - 2Web of Science - 3

Co-authors: Claflin SB; Campbell JA; Simpson-Yap S; Blizzard CL; van der Mei I; Taylor BVM

Tweet

2021Cox IA, Otahal P, de Graaff B, Corte TJ, Moodley Y, et al., 'Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia', Respirology, 27, (3) pp. 209-216. ISSN 1323-7799 (2021) [Refereed Article]

DOI: 10.1111/resp.14194 [eCite] [Details]

Citations: Scopus - 6Web of Science - 6

Co-authors: Cox IA; Otahal P; de Graaff B; Walters EH

Tweet

2021Cox IA, de Graaff B, Ahmed H, Campbell J, Otahal P, et al., 'The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia', Quality of Life Research, 30, (9) pp. 2615-2632. ISSN 0962-9343 (2021) [Refereed Article]

DOI: 10.1007/s11136-021-02879-1 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Co-authors: Cox IA; de Graaff B; Ahmed H; Campbell J; Otahal P; Walters EH

Tweet

2021Cox IA, de Graaff B, Corte TJ, Glaspole I, Chambers DC, et al., 'Recent trends in pirfenidone and nintedanib utilisation for idiopathic pulmonary fibrosis in Australia', Australian Health Review, 45, (6) pp. 718-727. ISSN 0156-5788 (2021) [Refereed Article]

DOI: 10.1071/AH20337 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Cox IA; de Graaff B; Walters EH

Tweet

2021Lo LMP, Taylor BVM, Winzenberg T, Palmer AJ, Blizzard L, et al., 'Comorbidity patterns in people with multiple sclerosis: A latent class analysis of the Australian Multiple Sclerosis Longitudinal Study', European Journal of Neurology, 28, (7) pp. 2269-2279. ISSN 1351-5101 (2021) [Refereed Article]

DOI: 10.1111/ene.14887 [eCite] [Details]

Citations: Scopus - 3Web of Science - 4

Co-authors: Taylor BVM; Winzenberg T; Blizzard L; Hussain MA; van der Mei I

Tweet

2021Palmer AJ, Campbell JA, de Graaff B, Devlin N, Ahmad H, et al., 'Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia', Health Economics pp. 1-28. ISSN 1057-9230 (2021) [Refereed Article]

DOI: 10.1002/hec.4281 [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Co-authors: Campbell JA; de Graaff B; Ahmad H; Si L

Tweet

2021Ravangard R, Jalali FS, Bayati M, Palmer AJ, Jafari A, et al., 'Household catastrophic health expenditure and its effective factors: a case of Iran', Cost Effectiveness and Resource Allocation, 19, (1) Article 59. ISSN 1478-7547 (2021) [Refereed Article]

DOI: 10.1186/s12962-021-00315-2 [eCite] [Details]

Citations: Scopus - 6Web of Science - 6

Tweet

2021Rezapour A, Palmer AJ, Alipour V, Hajahmadi M, Jafari A, 'The cost-effectiveness of B-type natriuretic peptide-guided care in compared to standard clinical assessment in outpatients with heart failure in Tehran, Iran', Cost Effectiveness and Resource Allocation, 19, (1) Article 81. ISSN 1478-7547 (2021) [Refereed Article]

DOI: 10.1186/s12962-021-00334-z [eCite] [Details]

Tweet

2021Si L, Eisman JA, Winzenberg T, Sanders KM, Center JR, et al., 'Development and validation of the risk engine for an Australian Health Economics Model of Osteoporosis', Osteoporosis International, 32, (10) pp. 2073-2081. ISSN 0937-941X (2021) [Refereed Article]

DOI: 10.1007/s00198-021-05955-x [eCite] [Details]

Co-authors: Winzenberg T

Tweet

2021Silva Ragaini B, Sharman MJ, Lyth A, Jose KA, Blizzard L, et al., 'Is greater public transport use associated with higher levels of physical activity in a regional setting? Findings from a pilot study', Pilot and Feasibility Studies, 7 Article 217. ISSN 2055-5784 (2021) [Refereed Article]

DOI: 10.1186/s40814-021-00951-8 [eCite] [Details]

Co-authors: Silva Ragaini B; Sharman MJ; Jose KA; Blizzard L; Peterson C; Johnston FH; Cleland VJ

Tweet

2021Singh A, Campbell JA, Venn A, Jones G, Blizzard L, et al., 'Association between knee symptoms, change in knee symptoms over 6-9 years, and SF-6D health state utility among middle-aged Australians', Quality of Life Research, 30, (9) pp. 2601-2613. ISSN 0962-9343 (2021) [Refereed Article]

DOI: 10.1007/s11136-021-02859-5 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Singh A; Campbell JA; Venn A; Jones G; Blizzard L; Dwyer T; Ding C; Antony B

Tweet

2021Singh A, Hussain S, Kher V, Palmer AJ, Jose M, et al., 'A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury', Expert Review of Pharmacoeconomics and Outcomes Research pp. 1-9. ISSN 1473-7167 (2021) [Refereed Article]

DOI: 10.1080/14737167.2021.1916471 [eCite] [Details]

Co-authors: Singh A; Jose M; Antony B

Tweet

2021Stanesby O, Morse M, Magill L, Ball K, Blizzard L, et al., 'Characteristics associated with willingness to walk further than necessary to the bus stop: Insights for public transport-related physical activity', Journal of Transport and Health, 22 pp. 1-12. ISSN 2214-1405 (2021) [Refereed Article]

DOI: 10.1016/j.jth.2021.101139 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Co-authors: Stanesby O; Blizzard L; Jose K; Sharman MJ; Cleland V

Tweet

2021Tran-Duy A, Knight J, Clarke PM, Svensson AM, Eliasson B, et al., 'Development of a life expectancy table for individuals with type 1 diabetes', Diabetologia, 64, (10) pp. 2228-2236. ISSN 0012-186X (2021) [Refereed Article]

DOI: 10.1007/s00125-021-05503-6 [eCite] [Details]

Citations: Scopus - 9Web of Science - 6

Tweet

2021Xia Q, Campbell J, Palmer AJ, 'The need for an improved evidence base to inform the health care decision-making process', JAMA Surgery ISSN 2168-6254 (2021) [Contribution to Refereed Journal]

DOI: 10.1001/jamasurg.2020.6378 [eCite] [Details]

Co-authors: Xia Q; Campbell J

Tweet

2021Xia Q, Campbell J, Si L, Ahmad H, de Graaff B, et al., 'Healthcare resource utilisation and predictors for critical care unit admissions after primary bariatric surgery in an Australian public hospital setting: an exploratory study using a mixed-methods approach', Australian Health Review ISSN 1449-8944 (2021) [Refereed Article]

[eCite] [Details]

Co-authors: Xia Q; Campbell J; Ahmad H; de Graaff B; Marrone J; Kuzminov A

2021Xia Q, Campbell JA, Ahmad H, Palmer AJ, 'Comment on: Bariatric surgery is expensive but improves co-morbidity: 5-year assessment of patients with obesity and type 2 diabetes', British Journal of Surgery, 108, (8) pp. e280. ISSN 0007-1323 (2021) [Letter or Note in Journal]

DOI: 10.1093/bjs/znab164 [eCite] [Details]

Co-authors: Xia Q; Campbell JA; Ahmad H

Tweet

2021Xia Q, Campbell JA, Ahmad H, de Graaff B, Si L, et al., 'Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system', The European Journal of Health Economics ISSN 1618-7598 (2021) [Refereed Article]

DOI: 10.1007/s10198-021-01405-x [eCite] [Details]

Co-authors: Xia Q; Campbell JA; Ahmad H; de Graaff B; Otahal P

Tweet

2021Zhao T, Winzenberg T, Aitken D, de Graaff B, Ahmad H, et al., 'The impact of comorbidities on health-related quality of life of people with osteoarthritis over 10 years', Rheumatology, 61, (1) pp. 139-145. ISSN 1462-0332 (2021) [Refereed Article]

DOI: 10.1093/rheumatology/keab358 [eCite] [Details]

Co-authors: Zhao T; Winzenberg T; Aitken D; de Graaff B; Ahmad H; Jones Graeme

Tweet

2020Ahmad H, Campbell JA, van der Mei I, Taylor BV, Zhao T, et al., 'The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: results from updated and detailed data on types of costs', Multiple Sclerosis and Related Disorders, 44 Article 102247. ISSN 2211-0348 (2020) [Refereed Article]

DOI: 10.1016/j.msard.2020.102247 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: Ahmad H; Campbell JA; van der Mei I; Taylor BV; Zhao T

Tweet

2020Ahmad H, van der Mei I, Taylor BV, Campbell JA, Palmer AJ, 'Measuring the health-related quality of life in Australians with Multiple Sclerosis using the Assessment of Quality of Life-8-Dimension (AQoL-8D) multi-attribute utility instrument', Multiple Sclerosis and Related Disorders, 44 pp. 1-10. ISSN 2211-0348 (2020) [Refereed Article]

DOI: 10.1016/j.msard.2020.102358 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: Ahmad H; van der Mei I; Taylor BV; Campbell JA

Tweet

2020Boden I, Robertson IK, Neil A, Reeve J, Palmer AJ, et al., 'Preoperative physiotherapy is cost-effective for preventing pulmonary complications after major abdominal surgery: a health economic analysis of a multicentre randomised trial', Journal of Physiotherapy, 66, (3) pp. 180-187. ISSN 1836-9553 (2020) [Refereed Article]

DOI: 10.1016/j.jphys.2020.06.005 [eCite] [Details]

Citations: Scopus - 14Web of Science - 15

Co-authors: Boden I; Robertson IK; Neil A

Tweet

2020Borchers Arriagada N, Palmer AJ, Bowman DMJS, Johnston FH, 'Exceedances of national air quality standards for particulate matter in Western Australia: sources and health-related impacts', Medical Journal of Australia, (March) pp. 1-2. ISSN 0025-729X (2020) [Refereed Article]

DOI: 10.5694/mja2.50547 [eCite] [Details]

Citations: Scopus - 19Web of Science - 3

Co-authors: Borchers Arriagada N; Bowman DMJS; Johnston FH

Tweet

2020Borchers Arriagada N, Palmer AJ, Bowman DMJS, Morgan GG, Jalaludin BB, et al., 'Unprecedented smoke-related health burden associated with the 2019-20 bushfires in eastern Australia', Medical Journal of Australia pp. 1-2. ISSN 0025-729X (2020) [Refereed Article]

DOI: 10.5694/mja2.50545 [eCite] [Details]

Citations: Scopus - 127Web of Science - 124

Co-authors: Borchers Arriagada N; Bowman DMJS; Johnston FH

Tweet

2020Borchers Arriagada N, Palmer AJ, Bowman DMJS, Williamson GJ, Johnston FH, 'Health impacts of ambient biomass smoke in Tasmania, Australia', International Journal of Environmental Research and Public Health, 17, (9) Article 3264. ISSN 1661-7827 (2020) [Refereed Article]

DOI: 10.3390/ijerph17093264 [eCite] [Details]

Citations: Scopus - 18Web of Science - 19

Co-authors: Borchers Arriagada N; Bowman DMJS; Williamson GJ; Johnston FH

Tweet

2020Campbell JA, Jelinek GA, Weiland TJ, Nag N, Neate SL, et al., 'SF-6D health state utilities for lifestyle, sociodemographic and clinical characteristics of a large international cohort of people with multiple sclerosis', Quality of Life Research, 29 pp. 2509-2527. ISSN 0962-9343 (2020) [Refereed Article]

DOI: 10.1007/s11136-020-02505-6 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: Campbell JA; Simpson-Yap S

Tweet

2020Campbell JA, Simpson Jr S, Ahmad H, Taylor BV, van der Mei I, et al., 'Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease modifying therapy prescription data', Multiple Sclerosis Journal, 26, (11) pp. 1315-1328. ISSN 1352-4585 (2020) [Refereed Article]

DOI: 10.1177/1352458519861270 [eCite] [Details]

Citations: Scopus - 27Web of Science - 28

Co-authors: Campbell JA; Simpson Jr S; Ahmad H; Taylor BV; van der Mei I

Tweet

2020Chen J, Taylor B, Blizzard L, Simpson-Yap S, Palmer AJ, et al., 'Risk factors for leaving employment due to multiple sclerosis and changes in risk over the past decades: using competing risk survival analysis', Multiple Sclerosis Journal pp. 1-12. ISSN 1352-4585 (2020) [Refereed Article]

DOI: 10.1177/1352458520954167 [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Co-authors: Chen J; Taylor B; Blizzard L; Simpson-Yap S; van der Mei I

Tweet

2020Cox IA, Borchers Arriagada N, de Graaff B, Corte TJ, Glaspole I, et al., 'Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis', European Respiratory Review, 29 Article 200154. ISSN 0905-9180 (2020) [Refereed Article]

DOI: 10.1183/16000617.0154-2020 [eCite] [Details]

Citations: Scopus - 12Web of Science - 12

Co-authors: Cox IA; Borchers Arriagada N; de Graaff B; Lartey S; Walters EH

Tweet

2020Cox IA, de Graaff B, Ahmed H, Campbell J, Otahal P, et al., 'The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study', The European Journal of Health Economics pp. 1-19. ISSN 1618-7601 (2020) [Refereed Article]

DOI: 10.1007/s10198-022-01538-7 [eCite] [Details]

Citations: Scopus - 1Web of Science - 2

Co-authors: Cox IA; de Graaff B; Ahmed H; Campbell J; Otahal P; Walters EH

Tweet

2020Haines TP, Palmer AJ, Tierney P, Si L, Robinson AL, 'A new model of care and in-house general practitioners for residential aged care facilities: a stepped wedge, cluster randomised trial', Medical Journal of Australia, 212, (9) pp. 409-415. ISSN 0025-729X (2020) [Refereed Article]

DOI: 10.5694/mja2.50565 [eCite] [Details]

Citations: Scopus - 12Web of Science - 10

Co-authors: Si L; Robinson AL

Tweet

2020Hensher M, Canny B, Zimitat C, Campbell J, Palmer A, 'Health care, overconsumption and uneconomic growth: a conceptual framework', Social Science and Medicine, 266 Article 113420. ISSN 0277-9536 (2020) [Refereed Article]

DOI: 10.1016/j.socscimed.2020.113420 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Co-authors: Hensher M; Canny B; Campbell J

Tweet

2020Holland AE, Corte T, Chambers DC, Palmer AJ, Ekstrom MP, et al., 'Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): A randomised controlled trial', BMJ Open, 10, (12) ISSN 2044-6055 (2020) [Refereed Article]

DOI: 10.1136/bmjopen-2020-040798 [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Tweet

2020Johnston FH, Borchers-Arriagada N, Morgan GG, Jalaludin B, Palmer AJ, et al., 'Unprecedented health costs of smoke-related PM2.5 from the 2019-20 Australian megafires', Nature Sustainability, (September) pp. 1-12. ISSN 2398-9629 (2020) [Refereed Article]

DOI: 10.1038/s41893-020-00610-5 [eCite] [Details]

Citations: Scopus - 85Web of Science - 78

Co-authors: Johnston FH; Borchers-Arriagada N; Williamson GJ; Bowman DMJS

Tweet

2020Lartey S, Si L, Lung T, Magnussen CG, Boateng GO, et al., 'Impact of overweight and obesity on life expectancy, quality-adjusted life years and lifetime costs in the adult population of Ghana', BMJ Global Health, 5, (9) Article e003332. ISSN 2059-7908 (2020) [Refereed Article]

DOI: 10.1136/bmjgh-2020-003332 [eCite] [Details]

Citations: Scopus - 5Web of Science - 3

Co-authors: Lartey S; Magnussen CG; de Graaff B; Blizzard L

Tweet

2020Lartey ST, Si L, Otahal P, de Graaff B, Boateng GO, et al., 'Annual transition probabilities of overweight and obesity in older adults: evidence from World Health Organization Study on global AGEing and adult health', Social Science and Medicine, 247 Article 112821. ISSN 0277-9536 (2020) [Refereed Article]

DOI: 10.1016/j.socscimed.2020.112821 [eCite] [Details]

Citations: Scopus - 12Web of Science - 12

Co-authors: Lartey ST; Si L; Otahal P; de Graaff B; Magnussen CG

Tweet

2020Lo LMP, Taylor BV, Winzenberg T, Palmer AJ, Blizzard L, et al., 'Comorbidities contribute substantially to the severity of common multiple sclerosis symptoms', Journal of Neurology, (September) pp. 1-10. ISSN 0340-5354 (2020) [Refereed Article]

DOI: 10.1007/s00415-020-10192-z [eCite] [Details]

Citations: Scopus - 3Web of Science - 2

Co-authors: Taylor BV; Winzenberg T; Blizzard L; van der Mei I

Tweet

2020Lo LMP, Taylor BV, Winzenberg T, Palmer AJ, Blizzard L, et al., 'Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis', Journal of Neurology, (September) pp. 1-13. ISSN 0340-5354 (2020) [Refereed Article]

DOI: 10.1007/s00415-020-10195-w [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Co-authors: Taylor BV; Winzenberg T; Blizzard L; Ahmad H; Hussain MA; van der Mei I

Tweet

2020Lo LMP, Taylor BV, Winzenberg T, Palmer AJ, Blizzard L, et al., 'Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis', Journal of Neurology, (September) pp. 1-11. ISSN 0340-5354 (2020) [Refereed Article]

DOI: 10.1007/s00415-020-10194-x [eCite] [Details]

Citations: Scopus - 6Web of Science - 6

Co-authors: Taylor BV; Winzenberg T; Blizzard L; van der Mei I

Tweet

2020Nguyen AL, Nguyen HTT, Yee KC, Palmer AJ, Blizzard CL, et al., 'A systematic review and narrative synthesis of health economic evaluations of Hepatocellular Carcinoma (HCC) screening strategies', Value in Health pp. 1-11. ISSN 1098-3015 (2020) [Refereed Article]

DOI: 10.1016/j.jval.2020.11.014 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Co-authors: Nguyen AL; Nguyen HTT; Yee KC; Blizzard CL; de Graaff B

Tweet

2020Ragaini BS, Sharman MJ, Lyth A, Jose KA, Blizzard L, et al., 'A mixed-methods study of the demographic and behavioural correlates of walking to a more distant bus stop', Transportation Research Interdisciplinary Perspectives, 6 Article 100164. ISSN 2590-1982 (2020) [Refereed Article]

DOI: 10.1016/j.trip.2020.100164 [eCite] [Details]

Citations: Scopus - 6

Co-authors: Ragaini BS; Sharman MJ; Jose KA; Blizzard L; Peterson C; Johnston FH; Aryal J; Cleland VJ

Tweet

2020Sharman MJ, Ball K, Greaves S, Jose KA, Morse M, et al., 'trips4health: Protocol of a single-blinded randomised controlled trial incentivising adults to use public transport for physical activity gain', Contemporary Clinical Trials Communications, 19 Article 100619. ISSN 2451-8654 (2020) [Contribution to Refereed Journal]

DOI: 10.1016/j.conctc.2020.100619 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Sharman MJ; Jose KA; Blizzard CL; Wells G; Venn AJ; Harpur S; Cleland VJ

Tweet

2020Si L, Tu L, Xie Y, Chen G, Hiligsmann M, et al., 'Evaluating health related quality of life in older people at risk of osteoporotic fracture: a head-to-head comparison of the EQ-5D-5L and AQoL-6D', Social Indicators Research pp. 1-16. ISSN 0303-8300 (2020) [Refereed Article]

DOI: 10.1007/s11205-020-02414-8 [eCite] [Details]

Citations: Web of Science - 1

Tweet

2020Si L, Willis MS, Asseburg C, Nilsson A, Tew M, et al., 'Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials: a report on the Ninth Mount Hood Diabetes Challenge', Value in Health, 23, (9) pp. 1163-1170. ISSN 1098-3015 (2020) [Refereed Article]

DOI: 10.1016/j.jval.2020.04.1832 [eCite] [Details]

Citations: Scopus - 21Web of Science - 22

Co-authors: Si L

Tweet

2020Stanesby O, Long M, Ball K, Blizzard L, Cocker F, et al., 'Socio-demographic, behavioural and health-related characteristics associated with active commuting in a regional Australian state: evidence from the 2016 Tasmanian Population Health Survey', Health Promotion Journal of Australia, (September) pp. 1-12. ISSN 2201-1617 (2020) [Refereed Article]

DOI: 10.1002/hpja.428 [eCite] [Details]

Citations: Scopus - 1Web of Science - 2

Co-authors: Stanesby O; Blizzard L; Cocker F; Johnston F; Jose K; Sharman M; Venn A; Cleland V

Tweet

2020Tran-Duy A, Knight J, Palmer AJ, Petrie D, Lung TW, et al., 'A patient-level model to estimate lifetime health outcomes of patients with type 1 diabetes', Diabetes Care, 43, (8) pp. 1741-1749. ISSN 0149-5992 (2020) [Refereed Article]

DOI: 10.2337/dc19-2249 [eCite] [Details]

Citations: Scopus - 10Web of Science - 10

Tweet

2020Xia Q, Campbell JA, Ahmad H, Si L, de Graaff B, et al., 'Health state utilities for economic evaluation of bariatric surgery: a comprehensive systematic review and meta-analysis', Obesity Reviews, 21, (8) Article e13028. ISSN 1467-7881 (2020) [Refereed Article]

DOI: 10.1111/obr.13028 [eCite] [Details]

Citations: Scopus - 7Web of Science - 7

Co-authors: Xia Q; Campbell JA; Ahmad H; Si L; de Graaff B; Otahal P

Tweet

2020Zhang Y, Taylor BV, Simpson Jr S, Blizzard L, Campbell JA, et al., 'Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype', Multiple Sclerosis Journal, (September) pp. 1-14. ISSN 1352-4585 (2020) [Refereed Article]

DOI: 10.1177/1352458520958369 [eCite] [Details]

Citations: Scopus - 19Web of Science - 17

Co-authors: Taylor BV; Simpson Jr S; Blizzard L; Campbell JA; van der Mei I

Tweet

2020Zhang Y, Taylor BV, Simpson Jr S, Blizzard L, Palmer AJ, et al., 'Validation of 0-10 MS symptom scores in the Australian multiple sclerosis longitudinal study', Multiple Sclerosis and Related Disorders, 39 Article 101895. ISSN 2211-0348 (2020) [Refereed Article]

DOI: 10.1016/j.msard.2019.101895 [eCite] [Details]

Citations: Scopus - 15Web of Science - 15

Co-authors: Taylor BV; Simpson Jr S; Blizzard L; van der Mei I

Tweet

2020Zhao T, Ahmad H, Winzenberg T, Aitken D, de Graaff B, et al., 'Cross-sectional and temporal differences in health-related quality of life of people with and without osteoarthritis: a 10-year prospective study', Rheumatology pp. 1-8. ISSN 1462-0324 (2020) [Refereed Article]

DOI: 10.1093/rheumatology/keaa787 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Co-authors: Zhao T; Ahmad H; Winzenberg T; Aitken D; de Graaff B; Jones G

Tweet

2020Zhao T, Ahmad H, de Graaff B, Xia Q, Winzenberg T, et al., 'A systematic review of the evolution of health-economic evaluation models of osteoarthritis', Arthritis Care & Research Article accepted manuscript. ISSN 2151-464X (2020) [Refereed Article]

DOI: 10.1002/acr.24410 [eCite] [Details]

Co-authors: Zhao T; Ahmad H; de Graaff B; Xia Q; Winzenberg T; Aitken D

Tweet

2020Zhao T, Winzenberg T, de Graaff B, Aitken D, Ahmad H, et al., 'A systematic review and meta-analysis of health state utility values for osteoarthritis-related conditions', Arthritis Care & Research ISSN 2151-464X (2020) [Refereed Article]

DOI: 10.1002/acr.24478 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Zhao T; Winzenberg T; de Graaff B; Aitken D; Ahmad H

Tweet

2019Borchers Arriagada N, Horsley JA, Palmer AJ, Morgan GG, Tham R, et al., 'Association between fire smoke fine particulate matter and asthma-related outcomes: systematic review and meta-analysis', Environmental Research, 179 Article 108777. ISSN 0013-9351 (2019) [Refereed Article]

DOI: 10.1016/j.envres.2019.108777 [eCite] [Details]

Citations: Scopus - 54Web of Science - 55

Co-authors: Borchers Arriagada N; Johnston FH

Tweet

2019Campbell JA, Hensher M, Davies D, Green M, Hagan B, et al., 'Long-term inpatient hospital utilisation and costs (2007-2008 to 2015-2016) for publicly waitlisted bariatric surgery patients in an Australian public hospital system based on Australia's activity-based funding model', PharmacoEconomics - Open, 3 pp. 599-618. ISSN 2509-4254 (2019) [Refereed Article]

DOI: 10.1007/s41669-019-0140-5 [eCite] [Details]

Citations: Scopus - 6Web of Science - 4

Co-authors: Campbell JA; Venn A; Kuzminov A; Neil A

Tweet

2019Canty D, Barth J, Yang Y, Peters N, Palmer A, et al., 'Comparison of learning outcomes for teaching focused cardiac ultrasound to physicians: a supervised human model course versus an eLearning guided self- directed simulator course', Journal of Critical Care, 49 pp. 38-44. ISSN 0883-9441 (2019) [Refereed Article]

DOI: 10.1016/j.jcrc.2018.10.006 [eCite] [Details]

Citations: Scopus - 4Web of Science - 6

Tweet

2019Chen J, Taylor B, Winzenberg T, Palmer AJ, Kirk-Brown A, et al., 'Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis', Multiple Sclerosis Journal, (June) pp. 1-10. ISSN 1352-4585 (2019) [Refereed Article]

DOI: 10.1177/1352458519872644 [eCite] [Details]

Citations: Scopus - 15Web of Science - 16

Co-authors: Chen J; Taylor B; Winzenberg T; Simpson Jr S; Blizzard L; van der Mei I

Tweet

2019Cocker F, Yee KC, Palmer AJ, de Graaff B, 'Increasing incidence and mortality related to liver cancer in Australia: time to turn the tide', Australian and New Zealand Journal of Public Health, 43, (3) pp. 267-273. ISSN 1753-6405 (2019) [Refereed Article]

DOI: 10.1111/1753-6405.12889 [eCite] [Details]

Citations: Scopus - 26Web of Science - 25

Co-authors: Cocker F; Yee KC; de Graaff B

Tweet

2019Eghdami A, Ostovar R, Jafari A, Palmer AJ, Bordbar N, et al., 'Economic burden of gastric cancer: A case study of Iran', Cancer Control, 26, (1) ISSN 1073-2748 (2019) [Refereed Article]

DOI: 10.1177/1073274819837185 [eCite] [Details]

Citations: Scopus - 11Web of Science - 10

Tweet

2019Kent S, Becker F, Feenstra T, Tran-Duy A, Schlackow I, et al., 'The challenge of transparency and validation in health economic decision modelling: a view from Mount Hood', PharmacoEconomics, 37 pp. 1305-1312. ISSN 1170-7690 (2019) [Refereed Article]

DOI: 10.1007/s40273-019-00825-1 [eCite] [Details]

Citations: Scopus - 20Web of Science - 22

Tweet

2019Kitic CM, Selig S, Davison K, Best TLB, Parmenter B, et al., 'Study protocol for a multicentre, controlled non-randomised trial: benefits of exercise physiology services for type 2 diabetes (BEST)', BMJ Open, 9, (8) Article e027610. ISSN 2044-6055 (2019) [Refereed Article]

DOI: 10.1136/bmjopen-2018-027610 [eCite] [Details]

Co-authors: Kitic CM; Hardcastle S; Cheney M; Williams AD

Tweet

2019Kuzminov A, Wilkinson S, Palmer AJ, Otahal P, Hensher M, et al., 'Rates and reasons for emergency department presentations of patients wait-listed for public bariatric surgery in Tasmania, Australia', Obesity Research and Clinical Practice, 13, (2) pp. 184-190. ISSN 1871-403X (2019) [Refereed Article]

DOI: 10.1016/j.orcp.2019.01.002 [eCite] [Details]

Co-authors: Kuzminov A; Otahal P; Hensher M; Venn AJ

Tweet

2019Lartey ST, Magnussen CG, Si L, Boateng GO, de Graaff B, et al., 'Rapidly increasing prevalence of overweight and obesity in older Ghanaian adults from 2007-2015: evidence from WHO-SAGE Waves 1 & 2', PLoS One, 14, (8) Article e0215045. ISSN 1932-6203 (2019) [Refereed Article]

DOI: 10.1371/journal.pone.0215045 [eCite] [Details]

Citations: Scopus - 22Web of Science - 22

Co-authors: Lartey ST; Magnussen CG; Si L; de Graaff B; Blizzard L

Tweet

2019Lartey ST, Magnussen CG, Si L, de Graaff B, Biritwum RB, et al., 'The role of intergenerational educational mobility and household wealth in adult obesity: evidence from wave 2 of the World Health Organization's study on global AGEing and adult health', PLoS ONE, 14, (1) Article e0208491. ISSN 1932-6203 (2019) [Refereed Article]

DOI: 10.1371/journal.pone.0208491 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: Lartey ST; Magnussen CG; Si L; de Graaff B

Tweet

2019Lartey ST, Si L, de Graaff B, Magnussen CG, Ahmad H, et al., 'Evaluation of the association between health state utilities and obesity in sub-Saharan Africa: evidence from World Health Organization Study on Global AGEing and Adult Health Wave 2', Value in Health, 22, (9) pp. 1042-1049. ISSN 1098-3015 (2019) [Refereed Article]

DOI: 10.1016/j.jval.2019.04.1925 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Lartey ST; Si L; de Graaff B; Magnussen CG; Ahmad H; Campbell J

Tweet

2019Lartey ST, de Graaff B, Magnussen CG, Boateng GO, Aikins M, et al., 'Health service utilization and direct healthcare costs associated with obesity in older adult population in Ghana', Health Policy and Planning pp. 1-11. ISSN 0268-1080 (2019) [Refereed Article]

DOI: 10.1093/heapol/czz147 [eCite] [Details]

Citations: Scopus - 9Web of Science - 6

Co-authors: Lartey ST; de Graaff B; Magnussen CG

Tweet

2019Palmer AJ, van der Mei I, Taylor BV, Clarke PM, Simpson Jr S, et al., 'Modelling the impact of multiple sclerosis on life expectancy, quality-adjusted life years and total lifetime costs: evidence from Australia', Multiple Sclerosis Journal pp. 1-10. ISSN 1352-4585 (2019) [Refereed Article]

DOI: 10.1177/1352458519831213 [eCite] [Details]

Citations: Scopus - 13Web of Science - 12

Co-authors: van der Mei I; Taylor BV; Simpson Jr S; Ahmad H

Tweet

2019Sharman MJ, Lyth A, Jose KA, Ragaini BS, Blizzard L, et al., 'Acceptability and perceived feasibility of strategies to increase public transport use for physical activity gain - a mixed methods study', Health Promotion Journal of Australia pp. 1-14. ISSN 2201-1617 (2019) [Refereed Article]

DOI: 10.1002/hpja.292 [eCite] [Details]

Citations: Scopus - 4Web of Science - 3

Co-authors: Sharman MJ; Jose KA; Ragaini BS; Blizzard L; Johnston FH; Peterson C; Cleland VJ

Tweet

2019Si L, Tu L, Xie Y, Palmer AJ, Gu Y, et al., 'Chinese patients' preference for pharmaceutical treatments of osteoporosis: a discrete choice experiment', Archives of Osteoporosis, 14, (1) Article 85. ISSN 1862-3522 (2019) [Refereed Article]

DOI: 10.1007/s11657-019-0624-z [eCite] [Details]

Citations: Scopus - 2Web of Science - 1

Tweet

2019Tran-Duy A, McDermott R, Knight J, Hua X, Barr ELM, et al., 'Development and use of prediction models for classification of cardiovascular risk of remote Indigenous Australians', Heart Lung and Circulation pp. 1-10. ISSN 1443-9506 (2019) [Refereed Article]

DOI: 10.1016/j.hlc.2019.02.005 [eCite] [Details]

Citations: Scopus - 3Web of Science - 2

Tweet

2019Wang Z, Zhou X, Gao Y, Chen M, Palmer AJ, et al., 'Did expansion of health insurance coverage reduce horizontal inequity in healthcare finance? A decomposition analysis for China', BMJ Open, 9, (1) Article e025184. ISSN 2044-6055 (2019) [Refereed Article]

DOI: 10.1136/bmjopen-2018-025184 [eCite] [Details]

Citations: Scopus - 5Web of Science - 4

Tweet

2019Xia Q, Campbell JA, Ahmad H, Si L, de Graaff B, et al., 'Bariatric surgery is a cost-saving treatment for obesity - a comprehensive meta-analysis and updated systematic review of health economic evaluations of bariatric surgery', Obesity Reviews pp. 1-15. ISSN 1467-7881 (2019) [Refereed Article]

DOI: 10.1111/obr.12932 [eCite] [Details]

Citations: Scopus - 34Web of Science - 28

Co-authors: Xia Q; Campbell JA; Ahmad H; Si L; de Graaff B

Tweet

2018Ahmad H, van der Mei I, Taylor BV, Lucas RM, Ponsonby A-L, et al., 'Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis', Multiple Sclerosis Journal pp. 1-9. ISSN 1352-4585 (2018) [Refereed Article]

DOI: 10.1177/1352458518806103 [eCite] [Details]

Citations: Scopus - 8Web of Science - 6

Co-authors: Ahmad H; van der Mei I; Taylor BV; Simpson S

Tweet

2018Campbell JA, Ezzy D, Neil A, Hensher M, Venn A, et al., 'A qualitative investigation of the health economic impacts of bariatric surgery for obesity and implications for improved practice in health economics', Health Economics, 27, (8) pp. 1300-1318. ISSN 1057-9230 (2018) [Refereed Article]

DOI: 10.1002/hec.3776 [eCite] [Details]

Citations: Scopus - 7Web of Science - 6

Co-authors: Campbell JA; Ezzy D; Neil A; Venn A; Sharman MJ

Tweet

2018Campbell JA, Hensher M, Neil A, Venn A, Otahal P, et al., 'An exploratory study: a head-to-head comparison of the EQ5D-5L and AQoL-8D for long-term publicly waitlisted bariatric surgery patients before and 3 months after bariatric surgery', PharmacoEconomics - Open, 2, (4) pp. 443-458. ISSN 2509-4254 (2018) [Refereed Article]

DOI: 10.1007/s41669-017-0060-1 [eCite] [Details]

Citations: Scopus - 10Web of Science - 10

Co-authors: Campbell JA; Neil A; Venn A; Otahal P

Tweet

2018Campbell JA, Hensher M, Neil A, Venn A, Wilkinson S, et al., 'An exploratory study of long-term publicly waitlisted bariatric surgery patients' quality of life before and 1 year after bariatric surgery, and considerations for healthcare planners', PharmacoEconomics Open, 2, (1) pp. 63-76. ISSN 2509-4254 (2018) [Refereed Article]

DOI: 10.1007/s41669-017-0038-z [eCite] [Details]

Citations: Scopus - 13Web of Science - 13

Co-authors: Campbell JA; Neil A; Venn A

Tweet

2018Canty DJ, Heiberg J, Yang Y, Royse AG, Margale S, et al., 'Pilot multi-centre randomised trial of the impact of pre-operative focused cardiac ultrasound on mortality and morbidity in patients having surgery for femoral neck fractures (ECHONOF-2 pilot)', Anaesthesia, 73, (4) pp. 428-437. ISSN 0003-2409 (2018) [Refereed Article]

DOI: 10.1111/anae.14130 [eCite] [Details]

Citations: Scopus - 31Web of Science - 27

Tweet

2018Chen J, Taylor B, Palmer AJ, Kirk-Brown A, van Dijk P, et al., 'Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis', Multiple Sclerosis Journal, (June) pp. 1-11. ISSN 1352-4585 (2018) [Refereed Article]

DOI: 10.1177/1352458518781971 [eCite] [Details]

Citations: Scopus - 37Web of Science - 33

Co-authors: Chen J; Taylor B; Simpson Jr S; Blizzard L; van der Mei I

Tweet

2018Chen J, Taylor BV, Blizzard L, Simpson Jr S, Palmer AJ, et al., 'Effects of multiple sclerosis disease-modifying therapies on employment measures using patient-reported data', Journal of Neurology, Neurosurgery and Psychiatry, 89, (11) pp. 1200-1207. ISSN 0022-3050 (2018) [Refereed Article]

DOI: 10.1136/jnnp-2018-318228 [eCite] [Details]

Citations: Scopus - 35Web of Science - 32

Co-authors: Chen J; Taylor BV; Blizzard L; Simpson Jr S; van der Mei IAF

Tweet

2018Kilpatrick M, Nelson M, Palmer A, Jose K, Venn A, 'Who discusses reaching a healthy weight with a general practitioner? Findings from the 2014-2015 Australian National Health Survey', Obesity Research and Clinical Practice, 12, (5) pp. 459-464. ISSN 1871-403X (2018) [Refereed Article]

DOI: 10.1016/j.orcp.2018.07.003 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Co-authors: Kilpatrick M; Nelson M; Jose K; Venn A

Tweet

2018Palmer AJ, Si L, Tew M, Hua X, Willis MS, et al., 'Computer modeling of diabetes and its transparency: a report on the Eighth Mount Hood Challenge', Value in Health, 21, (6) pp. 724-731. ISSN 1098-3015 (2018) [Refereed Article]

DOI: 10.1016/j.jval.2018.02.002 [eCite] [Details]

Citations: Scopus - 55Web of Science - 54

Co-authors: Si L

Tweet

2018Wang L, Cocker F, Kilpatrick M, Otahal P, Si L, et al., 'The associations of multimorbidity with health-related productivity loss in a large and diverse public sector setting: A cross-sectional survey', Journal of Occupational and Environmental Medicine, 60, (6) pp. 528-535. ISSN 1076-2752 (2018) [Refereed Article]

DOI: 10.1097/JOM.0000000000001243 [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Wang L; Cocker F; Kilpatrick M; Otahal P; Si L; Sanderson K

Tweet

2018Wang L, Si L, Cocker F, Palmer AJ, Sanderson K, 'A systematic review of cost-of-illness studies of multimorbidity', Applied Health Economics and Health Policy, 16, (1) pp. 15-29. ISSN 1175-5652 (2018) [Refereed Article]

DOI: 10.1007/s40258-017-0346-6 [eCite] [Details]

Citations: Scopus - 85Web of Science - 71

Co-authors: Wang L; Si L; Cocker F; Sanderson K

Tweet

2018de Graaff B, Yee KC, Clarke P, Palmer A, 'Uptake of and expenditure on direct-acting antiviral agents for Hepatitis C treatment in Australia', Applied Health Economics and Health Policy pp. 1-8. ISSN 1175-5652 (2018) [Refereed Article]

DOI: 10.1007/s40258-018-0392-8 [eCite] [Details]

Citations: Scopus - 7Web of Science - 5

Co-authors: de Graaff B; Yee KC

Tweet

2017Ahmad H, Taylor BV, van der Mei I, Colman S, O'Leary BA, et al., 'The impact of multiple sclerosis severity on health state utility values: Evidence from Australia', Multiple Sclerosis Journal, 23, (8) pp. 1157-1166. ISSN 1352-4585 (2017) [Refereed Article]

DOI: 10.1177/1352458516672014 [eCite] [Details]

Citations: Scopus - 23Web of Science - 24

Co-authors: Ahmad H; Taylor BV; van der Mei I; Breslin M

Tweet

2017Chen M, Palmer AJ, Si L, 'Improving equity in health care financing in China during the progression towards Universal Health Coverage', BMC Health Services Research, 17, (1) Article 852. ISSN 1472-6963 (2017) [Refereed Article]

DOI: 10.1186/s12913-017-2798-7 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: Si L

Tweet

2017Hua X, Lung TWC, Palmer A, Si L, Herman WH, et al., 'How consistent is the relationship between improved glucose control and modelled health outcomes for people with type 2 diabetes mellitus? a systematic review', PharmacoEconomics, 35, (3) pp. 319-329. ISSN 1170-7690 (2017) [Refereed Article]

DOI: 10.1007/s40273-016-0466-0 [eCite] [Details]

Citations: Scopus - 9Web of Science - 7

Co-authors: Si L

Tweet

2017Sharman MJ, Breslin MC, Kuzminov A, Palmer AJ, Blizzard L, et al., 'Population estimates and characteristics of Australians potentially eligible for bariatric surgery: findings from the 2011-13 Australian Health Survey', Australian Health Review pp. 1-9. ISSN 0156-5788 (2017) [Refereed Article]

DOI: 10.1071/AH16255 [eCite] [Details]

Citations: Scopus - 12Web of Science - 11

Co-authors: Sharman MJ; Breslin MC; Kuzminov A; Blizzard L; Hensher M; Venn AJ

Tweet

2017Sharman Melanie, Hensher M, Wilkinson S, Williams D, Palmer A, et al., 'What are the support experiences and needs of patients who have received bariatric surgery?', Health Expectations, 20, (1) pp. 35-46. ISSN 1369-6513 (2017) [Refereed Article]

DOI: 10.1111/hex.12423 [eCite] [Details]

Citations: Scopus - 28Web of Science - 17

Co-authors: Sharman Melanie; Williams D; Venn A; Ezzy D

Tweet

2017Si L, Chen M, Palmer AJ, 'Has equity in government subsidy on healthcare improved in China? Evidence from the China's National Health Services Survey', International Journal for Equity in Health, 16, (1) Article 6. ISSN 1475-9276 (2017) [Refereed Article]

DOI: 10.1186/s12939-017-0516-z [eCite] [Details]

Citations: Scopus - 16Web of Science - 16

Co-authors: Si L

Tweet

2017Si L, Shi L, Chen M, Palmer AJ, 'Establishing benchmark EQ-5D-3L population health state utilities and identifying their correlates in Gansu Province, China', Quality of Life Research, 26, (11) pp. 3049-3058. ISSN 0962-9343 (2017) [Refereed Article]

DOI: 10.1007/s11136-017-1614-5 [eCite] [Details]

Citations: Scopus - 10Web of Science - 10

Co-authors: Si L

Tweet

2017Wang L, Palmer AJ, Cocker F, Sanderson K, 'Multimorbidity and health-related quality of life (HRQoL) in a nationally representative population sample: implications of count versus cluster method for defining multimorbidity on HRQoL', Health and Quality of Life Outcomes, 15, (1) Article 7. ISSN 1477-7525 (2017) [Refereed Article]

DOI: 10.1186/s12955-016-0580-x [eCite] [Details]

Citations: Scopus - 35Web of Science - 35

Co-authors: Wang L; Sanderson K

Tweet

2017Wang L, Palmer AJ, Otahal P, Cocker F, Sanderson K, 'Multimorbidity and Health Care Service Utilization in the Australian Workforce', Journal of Occupational and Environmental Medicine, 59, (8) pp. 795-802. ISSN 1076-2752 (2017) [Refereed Article]

DOI: 10.1097/JOM.0000000000001089 [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Co-authors: Wang L; Otahal P; Cocker F; Sanderson K

Tweet

2017de Graaff B, Neil A, Sanderson K, Yee KC, Palmer AJ, 'Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study', Australian Health Review, 41, (3) pp. 254-267. ISSN 0156-5788 (2017) [Refereed Article]

DOI: 10.1071/AH15188 [eCite] [Details]

Citations: Scopus - 7Web of Science - 6

Co-authors: de Graaff B; Neil A; Sanderson K; Yee KC

Tweet

2017de Graaff B, Neil A, Si L, Yee KC, Sanderson K, et al., 'Cost-effectiveness of different population screening strategies for hereditary haemochromatosis in Australia', Applied Health Economics and Health Policy, 15, (4) pp. 521-534. ISSN 1175-5652 (2017) [Refereed Article]

DOI: 10.1007/s40258-016-0297-3 [eCite] [Details]

Citations: Scopus - 8Web of Science - 9

Co-authors: de Graaff B; Neil A; Si L; Yee KC; Sanderson K

Tweet

2017de Graaff B, Si L, Neil AL, Yee KC, Sanderson K, et al., 'Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model', PharmacoEconomics - Open, 1, (1) pp. 37-51. ISSN 2509-4254 (2017) [Refereed Article]

DOI: 10.1007/s41669-016-0005-0 [eCite] [Details]

Citations: Scopus - 3

Co-authors: de Graaff B; Si L; Neil AL; Yee KC; Sanderson K

Tweet

2016Annear MJ, Tierney LT, Vickers JC, Palmer AJ, 'Counting the cost of dementia-related hospital admissions: a regional investigation', Australasian Journal on Ageing, 35, (3) pp. E32-E35. ISSN 1440-6381 (2016) [Refereed Article]

DOI: 10.1111/ajag.12318 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: Annear MJ; Tierney LT; Vickers JC

Tweet

2016Campbell JA, Palmer AJ, Venn A, Sharman M, Otahal P, et al., 'A head-to-head comparison of the EQ-5D-5L and AQoL-8D multi-attribute utility instruments in patients who have previously undergone bariatric surgery', The Patient, 9, (4) pp. 311-322. ISSN 1178-1653 (2016) [Refereed Article]

DOI: 10.1007/s40271-015-0157-5 [eCite] [Details]

Citations: Scopus - 26Web of Science - 29

Co-authors: Campbell JA; Venn A; Sharman M; Otahal P; Neil A

Tweet

2016Campbell JA, Venn A, Neil A, Hensher M, Sharman M, et al., 'Diverse approaches to the health economic evaluation of bariatric surgery: a comprehensive systematic review', Obesity Reviews, 17, (9) pp. 850-894. ISSN 1467-7881 (2016) [Refereed Article]

DOI: 10.1111/obr.12424 [eCite] [Details]

Citations: Scopus - 17Web of Science - 16

Co-authors: Campbell JA; Venn A; Neil A; Sharman M

Tweet

2016Chen M, Palmer AJ, Si L, 'Assessing equity in benefit distribution of government health subsidy in 2012 across East China: benefit incidence analysis', International Journal for Equity in Health, 15 Article 15. ISSN 1475-9276 (2016) [Refereed Article]

DOI: 10.1186/s12939-016-0306-z [eCite] [Details]

Citations: Scopus - 12Web of Science - 12

Co-authors: Si L

Tweet

2016Chen M, Si L, Winzenberg TM, Gu J, Jiang Q, et al., 'Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence', Patient Preference and Adherence, 10 pp. 415-423. ISSN 1177-889X (2016) [Refereed Article]

DOI: 10.2147/PPA.S100175 [eCite] [Details]

Citations: Scopus - 5Web of Science - 4

Co-authors: Si L; Winzenberg TM

Tweet

2016Kuzminov A, Palmer AJ, Wilkinson S, Khatsiev B, Venn AJ, 'Re-operations after Secondary Bariatric Surgery: a Systematic Review', Obesity Surgery, 26, (9) pp. 2237-2247. ISSN 0960-8923 (2016) [Refereed Article]

DOI: 10.1007/s11695-016-2252-7 [eCite] [Details]

Citations: Scopus - 26Web of Science - 25

Co-authors: Kuzminov A; Venn AJ

Tweet

2016Neil AL, Nelson M, Palmer AJ, 'The new Australian after-hours general practice incentive payment mechanism: equity for rural general practice?', Health Policy, 120, (7) pp. 809-817. ISSN 0168-8510 (2016) [Refereed Article]

DOI: 10.1016/j.healthpol.2016.05.005 [eCite] [Details]

Co-authors: Neil AL; Nelson M

Tweet

2016Petrie D, Lung TW, Rawshani A, Palmer AJ, Svensson AM, et al., 'Recent trends in life expectancy for people with type 1 diabetes in Sweden', Diabetologia, 59, (6) pp. 1167-1176. ISSN 0012-186X (2016) [Refereed Article]

DOI: 10.1007/s00125-016-3914-7 [eCite] [Details]

Citations: Scopus - 67Web of Science - 65

Tweet

2016Sharman MJ, Venn AJ, Hensher M, Wilkinson S, Palmer AJ, et al., 'Motivations for Seeking Bariatric Surgery: The Importance of Health Professionals and Social Networks', Bariatric Surgical Practice and Patient Care, 11, (3) pp. 104-109. ISSN 2168-023X (2016) [Refereed Article]

DOI: 10.1089/bari.2016.0004 [eCite] [Details]

Citations: Scopus - 8Web of Science - 9

Co-authors: Sharman MJ; Venn AJ; Williams D; Ezzy D

Tweet

2016Sharman MJ, Venn AJ, Jose KA, Williams D, Hensher M, et al., 'The support needs of patients waiting for publicly funded bariatric surgery - implications for health service planners', Clinical Obesity, 7, (1) pp. 46-53. ISSN 1758-8103 (2016) [Refereed Article]

DOI: 10.1111/cob.12169 [eCite] [Details]

Citations: Scopus - 14

Co-authors: Sharman MJ; Venn AJ; Jose KA; Williams D; Ezzy D

Tweet

2016Si L, Winzenberg TM, Chen M, Jiang Q, Neil A, et al., 'Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study', Osteoporosis International, 27, (7) pp. 2259-2269. ISSN 0937-941X (2016) [Refereed Article]

DOI: 10.1007/s00198-016-3502-1 [eCite] [Details]

Citations: Scopus - 24Web of Science - 22

Co-authors: Si L; Winzenberg TM; Neil A

Tweet

2016de Graaff B, Neil A, Sanderson K, Yee KC, Palmer AJ, 'Quality of life utility values for hereditary haemochromatosis in Australia', Health and Quality of Life Outcomes, 14, (1) Article 31. ISSN 1477-7525 (2016) [Refereed Article]

DOI: 10.1186/s12955-016-0431-9 [eCite] [Details]

Citations: Scopus - 9Web of Science - 10

Co-authors: de Graaff B; Neil A; Sanderson K; Yee KC

Tweet

2015Baxter S, Campbell Sharon, Sanderson K, Cazaly C, Venn A, et al., 'Development of the Workplace Health Savings Calculator: a practical tool to measure economic impact from reduced absenteeism and staff turnover in workplace health promotion', BMC Research Notes, 8 Article 457. ISSN 1756-0500 (2015) [Refereed Article]

DOI: 10.1186/s13104-015-1402-7 [eCite] [Details]

Citations: Scopus - 15

Co-authors: Baxter S; Campbell Sharon; Sanderson K; Venn A

Tweet

2015Baxter S, Sanderson K, Venn A, Otahal P, Palmer AJ, 'Construct validity of SF-6D health state utility values in an employed population', Quality of Life Research, 24, (4) pp. 851-870. ISSN 1573-2649 (2015) [Refereed Article]

DOI: 10.1007/s11136-014-0823-4 [eCite] [Details]

Citations: Scopus - 10Web of Science - 11

Co-authors: Baxter S; Sanderson K; Venn A; Otahal P

Tweet

2015Curry BA, Hitchens PL, Otahal P, Si L, Palmer AJ, 'Workplace injuries in thoroughbred racing: An analysis of insurance payments and injuries amongst jockeys in Australia from 2002 to 2010', Animals, 5, (3) pp. 897-909. ISSN 2076-2615 (2015) [Refereed Article]

DOI: 10.3390/ani5030390 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Co-authors: Curry BA; Hitchens PL; Otahal P; Si L

Tweet

2015Curry BA, Hitchens PL, Otahal P, Si L, Palmer AJ, 'Australian insurance costs of jockeys injured in a race-day fall', Occupational Medicine, 66, (3) pp. 222-229. ISSN 1471-8405 (2015) [Refereed Article]

DOI: 10.1093/occmed/kqv150 [eCite] [Details]

Citations: Scopus - 13Web of Science - 12

Co-authors: Curry BA; Hitchens PL; Otahal P; Si L

Tweet

2015Hitchens PL, Curry B, Blizzard CL, Palmer AJ, 'A decision tree model for the implementation of a safety strategy in the horse-racing industry', Injury Prevention, 21, (2) pp. 109-114. ISSN 1475-5785 (2015) [Refereed Article]

DOI: 10.1136/injuryprev-2014-041223 [eCite] [Details]

Citations: Scopus - 3Web of Science - 4

Co-authors: Hitchens PL; Curry B; Blizzard CL

Tweet

2015Neil AL, Nelson MR, Richardson T, Mann-Leonard M, Palmer AJ, 'General practice after-hours incentive funding: a rationale for change', Medical Journal of Australia, 203, (2) pp. 82-85. ISSN 0025-729X (2015) [Refereed Article]

DOI: 10.5694/mja14.01229 [eCite] [Details]

Citations: Scopus - 5Web of Science - 5

Co-authors: Neil AL; Nelson MR

Tweet

2015Palmer AJ, Si L, Gordon JM, Saul T, Otahal P, et al., 'Investigating the costs of major and minor cycling crashes in Tasmania, Australia', Australian and New Zealand Journal of Public Health, 39, (5) pp. 485-490. ISSN 1753-6405 (2015) [Refereed Article]

DOI: 10.1111/1753-6405.12384 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Si L; Gordon JM; Saul T; Otahal P; Hitchens PL

Tweet

2015Si L, Winzenberg TM, Chen M, Jiang Q, Palmer AJ, 'Residual lifetime and 10 year absolute risks of osteoporotic fractures in Chinese men and women', Current Medical Research and Opinion, 31, (6) pp. 1149-1156. ISSN 0300-7995 (2015) [Refereed Article]

DOI: 10.1185/03007995.2015.1037729 [eCite] [Details]

Citations: Scopus - 37Web of Science - 36

Co-authors: Si L; Winzenberg TM

Tweet

2015Si L, Winzenberg TM, Jiang Q, Chen M, Palmer AJ, 'Projection of osteoporosis-related fractures and costs in China: 2010-2050', Osteoporosis International, 26, (7) pp. 1929-1937. ISSN 0937-941X (2015) [Refereed Article]

DOI: 10.1007/s00198-015-3093-2 [eCite] [Details]

Citations: Scopus - 240Web of Science - 208

Co-authors: Si L; Winzenberg TM

Tweet

2015Si L, Winzenberg TM, Jiang Q, Palmer AJ, 'Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model', Osteoporosis International, 26, (5) pp. 1477-1489. ISSN 0937-941X (2015) [Refereed Article]

DOI: 10.1007/s00198-014-2999-4 [eCite] [Details]

Citations: Scopus - 16Web of Science - 16

Co-authors: Si L; Winzenberg TM

Tweet

2015de Graaff B, Neil A, Sanderson K, Si L, Yee KC, et al., 'A systematic review and narrative synthesis of health economic studies conducted for hereditary haemochromatosis', Applied Health Economics and Health Policy, 13, (5) pp. 469-483. ISSN 1175-5652 (2015) [Refereed Article]

DOI: 10.1007/s40258-015-0189-y [eCite] [Details]

Citations: Scopus - 8Web of Science - 7

Co-authors: de Graaff B; Neil A; Sanderson K; Si L; Yee KC

Tweet

2014Baxter S, Sanderson K, Venn AJ, Blizzard CL, Palmer AJ, 'The relationship between return on investment and quality of study methodology in workplace health promotion programs', American Journal of Health Promotion, 28, (6) pp. 347-363. ISSN 0890-1171 (2014) [Refereed Article]

DOI: 10.4278/ajhp.130731-LIT-395 [eCite] [Details]

Citations: Scopus - 115Web of Science - 99

Co-authors: Baxter S; Sanderson K; Venn AJ; Blizzard CL

Tweet

2014Cocker F, Nicholson JM, Graves N, Oldenburg B, Palmer AJ, et al., 'Depression in working adults: comparing the costs and health outcomes of working when ill', PLoS ONE, 9, (9) Article e105430. ISSN 1932-6203 (2014) [Refereed Article]

DOI: 10.1371/journal.pone.0105430 [eCite] [Details]

Citations: Scopus - 23Web of Science - 19

Co-authors: Cocker F; Martin A; Scott J; Venn A; Sanderson K

Tweet

2014De Smit E, Palmer AJ, Hewitt AW, 'Projected worldwide disease burden from giant cell arteritis by 2050', Journal of Rheumatology, 42, (1) pp. 119-125. ISSN 1499-2752 (2014) [Refereed Article]

DOI: 10.3899/jrheum.140318 [eCite] [Details]

Citations: Scopus - 60Web of Science - 61

Co-authors: Hewitt AW

Tweet

2014Elliott K-E, Annear MJ, Bell EJ, Palmer AJ, Robinson AL, 'Residents with mild cognitive decline and family members report health students 'enhance capacity of care' and bring 'a new breath of life' in two aged care facilities in Tasmania', Health Expectations pp. 1-14. ISSN 1369-6513 (2014) [Refereed Article]

DOI: 10.1111/hex.12236 [eCite] [Details]

Citations: Scopus - 9Web of Science - 9

Co-authors: Elliott K-E; Annear MJ; Bell EJ; Robinson AL

Tweet

2014Liebl A, Seitz L, Palmer AJ, 'Health economics analysis of insulin aspart vs. regular human insulin in Type 2 Diabetes patients, based on observational real life evidence from general practices in Germany', Experimental and Clinical Endocrinology & Diabetes, 122, (9) pp. 517-522. ISSN 0947-7349 (2014) [Refereed Article]

DOI: 10.1055/s-0034-1376987 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Tweet

2014Lung TWC, Hayes AJ, Herman WH, Si L, Palmer AJ, et al., 'A meta-analysis of the relative risk of mortality for type 1 diabetes patients compared to the general population: exploring temporal changes in relative mortality', PL o S One, 9, (11) Article e113635. ISSN 1932-6203 (2014) [Refereed Article]

DOI: 10.1371/journal.pone.0113635 [eCite] [Details]

Citations: Scopus - 22Web of Science - 23

Co-authors: Si L

Tweet

2014Lung TWC, Petrie D, Herman WH, Palmer AJ, Svensson AM, et al., 'Severe hypoglycemia and mortality after cardiovascular events for Type 1 diabetic patients in Sweden', Diabetes Care, 37, (11) pp. 2974-2981. ISSN 0149-5992 (2014) [Refereed Article]

DOI: 10.2337/dc14-0405 [eCite] [Details]

Citations: Scopus - 41Web of Science - 37

Tweet

2014Palmer AJ, Si L, Gordon JM, Saul T, Curry BA, et al., 'Accident rates amongst regular bicycle riders in Tasmania, Australia', Accident Analysis and Prevention, 72 pp. 376-381. ISSN 0001-4575 (2014) [Refereed Article]

DOI: 10.1016/j.aap.2014.07.015 [eCite] [Details]

Citations: Scopus - 9Web of Science - 10

Co-authors: Si L; Gordon JM; Saul T; Curry BA; Otahal P; Hitchens PL

Tweet

2014Si L, Winzenberg TM, Palmer AJ, 'A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures', Osteoporosis International, 25, (1) pp. 51-60. ISSN 0937-941X (2014) [Refereed Article]

DOI: 10.1007/s00198-013-2551-y [eCite] [Details]

Citations: Scopus - 45Web of Science - 37

Co-authors: Si L; Winzenberg TM

Tweet

2014Si L, Winzenberg TM, de Graaff B, Palmer AJ, 'A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions', Osteoporosis International, 25, (8) pp. 1987-1997. ISSN 0937-941X (2014) [Refereed Article]

DOI: 10.1007/s00198-014-2636-2 [eCite] [Details]

Citations: Scopus - 69Web of Science - 66

Co-authors: Si L; Winzenberg TM; de Graaff B

Tweet

2013McKercher CM, Venn AJ, Blizzard L, Nelson MR, Palmer AJ, et al., 'Psychosocial factors in adults with chronic kidney disease: characteristics of pilot participants in the Tasmanian Chronic Kidney Disease study', BMCNephrology, 14 Article 83. ISSN 1471-2369 (2013) [Refereed Article]

DOI: 10.1186/1471-2369-14-83 [eCite] [Details]

Citations: Scopus - 26Web of Science - 26

Co-authors: McKercher CM; Venn AJ; Blizzard L; Nelson MR; Ashby MA; Scott JL; Jose MD

Tweet

2013Palmer AJ, 'Computer modeling of diabetes and its complications: a report on the fifth Mount Hood challenge meeting', Value in Health, 16, (4) pp. 670-685. ISSN 1098-3015 (2013) [Refereed Article]

DOI: 10.1016/j.jval.2013.01.002 [eCite] [Details]

Citations: Scopus - 110Web of Science - 93

Tweet

2013Palmer AJ, Colman S, O'Leary B, Taylor BV, Simmons RD, 'The economic impact of multiple sclerosis in Australia in 2010', Multiple Sclerosis, 19, (12) pp. 1640-1646. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513488230 [eCite] [Details]

Citations: Scopus - 62Web of Science - 53

Co-authors: Taylor BV

Tweet

2013Palmer AJ, Hitchens PL, Simpson Jr S, O'Leary B, Colman S, et al., 'A novel method for calculating prevalence of multiple sclerosis in Australia', Multiple Sclerosis, 19, (13) pp. 1704-1711. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513479841 [eCite] [Details]

Citations: Scopus - 17Web of Science - 16

Co-authors: Hitchens PL; Simpson Jr S; Taylor BV

Tweet

2013Taylor BV, Palmer A, Simpson Jr S, Lucas R, Simmons RD, et al., 'Assessing possible selection bias in a national voluntary MS longitudinal study in Australia', Multiple Sclerosis, 19, (12) pp. 1627-1631. ISSN 1352-4585 (2013) [Refereed Article]

DOI: 10.1177/1352458513481511 [eCite] [Details]

Citations: Scopus - 49Web of Science - 46

Co-authors: Taylor BV; Simpson Jr S

Tweet

2012Cooper MS, Palmer AJ, Seibel MJ, 'Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study', Osteoporosis International, 23, (1) pp. 97-107. ISSN 1433-2965 (2012) [Refereed Article]

DOI: 10.1007/s00198-011-1802-z [eCite] [Details]

Citations: Scopus - 82Web of Science - 74

Tweet

2012Hitchens PL, Palmer AJ, 'Characteristics of, and insurance payments for, injuries to cyclists in Tasmania, 1990-2010', Accident Analysis & Prevention, 49 pp. 449-456. ISSN 0001-4575 (2012) [Refereed Article]

DOI: 10.1016/j.aap.2012.03.013 [eCite] [Details]

Citations: Scopus - 5Web of Science - 4

Co-authors: Hitchens PL

Tweet

2012Palmer AJ, Tucker DMD, 'Cost and clinical implications of diabetes prevention in an Australian setting: A long-term modeling analysis', Primary Care Diabetes, 6, (2) pp. 109-121. ISSN 1751-9918 (2012) [Refereed Article]

DOI: 10.1016/j.pcd.2011.10.006 [eCite] [Details]

Citations: Scopus - 33Web of Science - 37

Co-authors: Tucker DMD

Tweet

2011Valentine WJ, Palmer AJ, Lammert M, Langer J, Brandle M, 'Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents', Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 33, (11) pp. 1698-1712. ISSN 0149-2918 (2011) [Refereed Article]

DOI: 10.1016/j.clinthera.2011.09.022 [eCite] [Details]

Citations: Scopus - 18Web of Science - 16

Tweet

2009Valentine WJ, Tucker D, Palmer AJ, Minshall ME, Foos V, et al., 'Long-Term Cost-Effectiveness of Pioglitazone versus Placebo in Addition to Existing Diabetes Treatment: A US Analysis Based on PROactive', Value in Health, 12, (1) pp. 1-9. ISSN 1098-3015 (2009) [Refereed Article]

DOI: 10.1111/j.1524-4733.2008.00403.x [eCite] [Details]

Citations: Scopus - 9Web of Science - 10

Tweet

2008Chirakup S, Chaiyakunapruk N, Chaikledkeaw U, Pongcharoensuk P, Ongphiphadhanakul B, et al., 'Cost-effectiveness analysis of thiazolidinediones in uncontrolled type 2 diabetic patients receiving sulfonylureas and metformin in Thailand', Value in Health, 11, (Supplement 1) pp. S43-S51. ISSN 1098-3015 (2008) [Refereed Article]

DOI: 10.1111/j.1524-4733.2008.00366.x [eCite] [Details]

Citations: Scopus - 15Web of Science - 10

Tweet

2008Gaede P, Valentine WJ, Palmer AJ, Tucker DMD, Lammert M, et al., 'Cost-effectiveness of Intensified versus conventional multifactorial intervention in type 2 diabetes: Results and projections from the Steno-2 study', Diabetes Care, 31, (8) pp. 1510-1515. ISSN 0149-5992 (2008) [Refereed Article]

DOI: 10.2337/dc07-2452 [eCite] [Details]

Citations: Scopus - 124Web of Science - 112

Tweet

2008Goodall G, Jendle JH, Valentine WJ, Munro V, Brandt AB, et al., 'Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naive type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting', International Journal of Clinical Practice, 62, (6) pp. 869-876. ISSN 1368-5031 (2008) [Refereed Article]

DOI: 10.1111/j.1742-1241.2008.01766.x [eCite] [Details]

Citations: Scopus - 14Web of Science - 10

Tweet

2008Minshall ME, Oglesby AK, Wintle ME, Valentine WJ, Roze S, et al., 'Estimating the long-term cost-effectiveness of exenatide in the United States: an adjunctive treatment for type 2 diabetes mellitus', Value in Health, 11, (1) pp. 22-33. ISSN 1098-3015 (2008) [Refereed Article]

DOI: 10.1111/j.1524-4733.2007.00211.x [eCite] [Details]

Citations: Scopus - 33Web of Science - 29

Tweet

2008Palmer AJ, Lammert M, Hermansen K, 'Health economic consequences of insulin analogues in the treatment of type 1 diabetes in Denmark', Ugeskrift for Laeger , 170, (15) pp. 1250-1254. ISSN 1603-6824 (2008) [Refereed Article]

PMID: 18433583 [eCite] [Details]

Citations: Scopus - 9

Tweet

2008Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, et al., 'A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA', Nephrology, Dialysis and Transplantation, 23, (4) pp. 1216-1223. ISSN 0931-0509 (2008) [Refereed Article]

DOI: 10.1093/ndt/gfn082 [eCite] [Details]

Citations: Scopus - 58Web of Science - 54

Tweet

2008Palmer JL, Goodall G, Nielsen S, Kotchie RW, Valentine WJ, et al., 'Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study', Current Medical Research and Opinion, 24, (5) pp. 1417-1428 . ISSN 0300-7995 (2008) [Refereed Article]

DOI: 10.1185/030079908X297295 [eCite] [Details]

Citations: Scopus - 17Web of Science - 12

Tweet

2008Ray JA, Borker R, Barber B, Valentine WJ, Belozeroff V, et al., 'Cost-Effectiveness of Early versus Late Cinacalcet Treatment in Addition to Standard Care for Secondary Renal Hyperparathyroidism in the USA', Value in Health, 11, (5) pp. 800-808. ISSN 1098-3015 (2008) [Refereed Article]

DOI: 10.1111/j.1524-4733.2008.00329.x [eCite] [Details]

Citations: Scopus - 14Web of Science - 13

Tweet

2008Valentine WJ, Goodall G, Aagren M, Nielsen S, Palmer AJ, et al., 'Evaluating the cost-effectiveness of therapy conversion to insulin detemir in patients with type 2 diabetes in Germany: a modelling study of long-term clinical and cost outcomes', Advances in Therapy: The International Journal of Drug, Device and Diagnostic Research, 25, (6) pp. 567-584. ISSN 0741-238X (2008) [Refereed Article]

DOI: 10.1007/s12325-008-0069-z [eCite] [Details]

Citations: Scopus - 23Web of Science - 15

Tweet

2007Alberti KGMM, Zimmet P, Shaw J, Unwin N, Orchard T, et al., 'International Diabetes Federation: a consensus on Type 2 diabetes prevention', Diabetic Medicine, 24, (5) pp. 451-463. ISSN 0742-3071 (2007) [Refereed Article]

DOI: 10.1111/j.1464-5491.2007.02157.x [eCite] [Details]

Citations: Scopus - 515Web of Science - 452

Tweet

2007Annemans L, Demarteau N, Hu SL, Lee TJ, Morad Z, et al., 'An Asian Regional Analysis of Cost-Effectiveness of Early Irbesartan Treatment versus Conventional Antihypertensive, Late Amlodipine, and Late Irbesartan Treatments in Patients with Type 2 Diabetes, Hypertension, and Nephropathy', Value in Health, 11, (3) pp. 354-364. ISSN 1098-3015 (2007) [Refereed Article]

DOI: 10.1111/j.1524-4733.2007.00250.x [eCite] [Details]

Citations: Scopus - 16Web of Science - 15

Tweet

2007Cohen N, Minshall ME, Sharon-Nash L, Zakrzewska K, Valentine WJ, et al., 'Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin: Economic Comparison in Adult and Adolescent Type 1 Diabetes Mellitus in Australia', Pharmacoeconomics, 25, (10) pp. 881-897. ISSN 1170-7690 (2007) [Refereed Article]

DOI: 10.2165/00019053-200725100-00006 [eCite] [Details]

Citations: Scopus - 41Web of Science - 29

Tweet

2007Coyle D, Rodby R, Soroka S, Levin A, Muirhead N, et al., 'Cost-effectiveness of irbesartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabetes and renal disease: a Canadian perspective', Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 29, (7) pp. 1508-1523. ISSN 0149-2918 (2007) [Refereed Article]

DOI: 10.1016/j.clinthera.2007.07.029 [eCite] [Details]

Citations: Scopus - 14Web of Science - 13

Tweet

2007Erny-Albrecht K, Valentine WJ, Christensen J, Vestenbaek U, Palmer AJ, 'Sublingual Immunotherapy in Allergic Rhinitis and Asthma: A Review of Recent Clinical Evidence', Journal of Applied Research: in Clinical and Experimental Therapeutics, 7, (1) pp. 17-31. ISSN 1537-064X (2007) [Refereed Article]

[eCite] [Details]

2007Gilmer TP, Roze S, Valentine WJ, Emy-Albrecht K, Ray JA, et al., 'Cost-effectiveness of diabetes case management for low-income populations', Health Services Research, 42, (5) pp. 1943-1959. ISSN 0017-9124 (2007) [Refereed Article]

DOI: 10.1111/j.1475-6773.2007.00701.x [eCite] [Details]

Citations: Scopus - 63Web of Science - 56

Tweet

2007Palmer AJ, Roze S, Valentine WJ, McEwan P, Gillett M, et al., 'Computer modeling of diabetes and its complications - A report on the Fourth Mount Hood Challenge Meeting', Diabetes Care, 30, (6) pp. 1638-1646. ISSN 0149-5992 (2007) [Refereed Article]

DOI: 10.2337/dc07-9919 [eCite] [Details]

Citations: Scopus - 189Web of Science - 169

Tweet

2007Palmer AJ, Valentine WJ, Ray JA, 'Irbesartan treatment of patients with type 2 diabetes, hypertension and renal disease: a UK health economics analysis', International Journal of Clinical Practice, 61, (10) pp. 1626-1633. ISSN 1368-5031 (2007) [Refereed Article]

DOI: 10.1111/j.1742-1241.2007.01343.x [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Tweet

2007Palmer AJ, Valentine WJ, Ray JA, Foos V, Lurati F, et al., 'An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK', Current Medical Research and Opinion, 23, (4) pp. 895-901. ISSN 0300-7995 (2007) [Refereed Article]

DOI: 10.1185/030079907X182194 [eCite] [Details]

Citations: Scopus - 28Web of Science - 23

Tweet

2007Palmer AJ, Valentine WJ, Ray JA, Roze S, Muszbek N, 'Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis', The European Journal of Health Economics, 8, (2) pp. 161-168. ISSN 1618-7598 (2007) [Refereed Article]

DOI: 10.1007/s10198-006-0033-2 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Tweet

2007Ray JA, Boye KS, Yurgin N, Valentine WJ, Roze S, et al., 'Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes', Current Medical Research and Opinion, 23, (3) pp. 609-622. ISSN 0300-7995 (2007) [Refereed Article]

DOI: 10.1185/030079907X178685 [eCite] [Details]

Citations: Scopus - 51Web of Science - 39

Tweet

2007Ray JA, Valentine WJ, Palmer AJ, 'Cost-utility analysis of cinacalcet in addition to standard of care in the UK', Nephrology, Dialysis and Transplantation, 22, (11) pp. 3355-3357. ISSN 0931-0509 (2007) [Refereed Article]

DOI: 10.1093/ndt/gfm434 [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Tweet

2007Ray JA, Valentine WJ, Roze S, Nicklasson L, Cobden D, et al., 'Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US', Diabetes Obesity & Metabolism, 9, (1) pp. 103-113. ISSN 1462-8902 (2007) [Refereed Article]

DOI: 10.1111/j.1463-1326.2006.00581.x [eCite] [Details]

Citations: Scopus - 27Web of Science - 22

Tweet

2007Valentine WJ, Bottomley JM, Palmer AJ, Brandle M, Foos V, et al., 'PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK', Diabetic Medicine, 24, (9) pp. 982-1002. ISSN 0742-3071 (2007) [Refereed Article]

DOI: 10.1111/j.1464-5491.2007.02188.x [eCite] [Details]

Citations: Scopus - 28Web of Science - 25

Tweet

2007Valentine WJ, Erny-Albrecht KM, Ray JA, Roze S, Cobden D, et al., 'Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States', Advances in Therapy: The International Journal of Drug, Device and Diagnostic Research, 24, (2) pp. 273-290. ISSN 0741-238X (2007) [Refereed Article]

DOI: 10.1007/BF02849895 [eCite] [Details]

Citations: Scopus - 23Web of Science - 15

Tweet

2006Bottomley J, Palmer AJ, Williams R, Dormandy J, Massi-Benedetti M, 'PROactive 03: Pioglitazone, type 2 diabetes and reducing macrovascular events - economic implications?', British Journal of Diabetes and Vascular Disease , 6, (2) pp. 63-70. ISSN 1474-6514 (2006) [Refereed Article]

DOI: 10.1177/14746514060060020401 [eCite] [Details]

Citations: Scopus - 7

Tweet

2006Currie CJ, McEwan P, Poole C, Valentine WJ, Palmer AJ, et al., 'Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naive type 2 diabetes patients: cost-effectiveness analysis in the UK setting', Current Medical Research and Opinion, 22, (5) pp. 967-969. ISSN 0300-7995 (2006) [Letter or Note in Journal]

DOI: 10.1185/030079906X00000 [eCite] [Details]

Citations: Web of Science - 3

Tweet

2006Palmer AJ, Chen R, Valentine WJ, Roze S, Bregman B, et al., 'Cost-consequence analysis in a French setting of screening and optimal treatment of nephropathy in hypertensive patients with type 2 diabetes', Diabetes & Metabolism, 32, (1) pp. 69-76. ISSN 1262-3636 (2006) [Refereed Article]

DOI: 10.1016/S1262-3636(07)70249-5 [eCite] [Details]

Citations: Scopus - 13Web of Science - 12

Tweet

2006Palmer AJ, Currie CJ, 'Modelling lifetime metabolic progression and cost effectiveness of treatment strategies for type 2 diabetes', Pharmacoeconomics, 24, (9) pp. 927-929. ISSN 1170-7690 (2006) [Contribution to Refereed Journal]

DOI: 10.2165/00019053-200624090-00009 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Tweet

2006Palmer AJ, Dinneen S, Gavin JR, Gray A, Herman WH, et al., 'Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes', Current Medical Research and Opinion, 22, (5) pp. 861-872. ISSN 0300-7995 (2006) [Refereed Article]

DOI: 10.1185/030079906X104669 [eCite] [Details]

Citations: Scopus - 45Web of Science - 31

Tweet

2006Palmer AJ, Roze S, Rodby RA, Valentine WJ, Ritz E, et al., 'Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy', Deutsche Medizinische Wochenschrift, 131, (31-32) pp. 1721-1726. ISSN 0012-0472 (2006) [Refereed Article]

DOI: 10.1055/s-2006-947822 [eCite] [Details]

Citations: Scopus - 7Web of Science - 7

Tweet

2006Palmer AJ, Roze S, Valentine WJ, Ray JA, Frei A, et al., 'Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patients with type 2 diabetes, hypertension, and renal disease in Switzerland', Swiss Medical Weekly, 136, (21-22) pp. 346-352. ISSN 1424-7860 (2006) [Refereed Article]

PMID: 16779715 [eCite] [Details]

Citations: Scopus - 6Web of Science - 5

Tweet

2006Palmer AJ, Valentine WJ, Tucker DMD, Ray JA, Roze S, et al., 'A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension', Current Medical Research and Opinion, 22, (11) pp. 2095-2100. ISSN 0300-7995 (2006) [Refereed Article]

DOI: 10.1185/030079906X132730 [eCite] [Details]

Citations: Scopus - 8Web of Science - 8

Tweet

2006Roze S, Liens D, Palmer AJ, Berger W, Tucker D, et al., 'A health economic model to determine the long-term costs and clinical outcomes of raising low HDL-cholesterol in the prevention of coronary heart disease', Current Medical Research and Opinion, 22, (12) pp. 2549-2556. ISSN 0300-7995 (2006) [Refereed Article]

DOI: 10.1185/030079906X148490 [eCite] [Details]

Citations: Scopus - 7Web of Science - 5

Tweet

2006Roze S, Valentine WJ, Evers T, Palmer AJ, 'Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting', Current Medical Research and Opinion, 22, (7) pp. 1415-1424. ISSN 0300-7995 (2006) [Refereed Article]

DOI: 10.1185/030079906X115531 [eCite] [Details]

Citations: Scopus - 8Web of Science - 6

Tweet

2006Roze S, Valentine WJ, Zakrzewska K, Palmer AJ, 'Cost-effectiveness of CSII - Response (Response to the letter by Philip Home)', Diabetic Medicine, 23, (6) pp. 707-708. ISSN 0742-3071 (2006) [Letter or Note in Journal]

DOI: 10.1111/j.1464-5491.2006.1854_2.x [eCite] [Details]

Tweet

2006Tucker DMD, Palmer AJ, Valentine WJ, Roze S, Ray JA, 'Counting the costs of overweight and obesity: modeling clinical and cost outcomes', Current Medical Research and Opinion, 22, (3) pp. 575-586. ISSN 0300-7995 (2006) [Refereed Article]

DOI: 10.1185/030079906X96227 [eCite] [Details]

Citations: Scopus - 35Web of Science - 31

Tweet

2006Valentine WJ, Palmer AJ, Erny-Albrecht KM, Ray JA, Cobden D, et al., 'Cost-effectiveness of basal insulin from a US health system perspective: Comparative analyses of detemir, glargine, and NPH', Advances in Therapy: The International Journal of Drug, Device and Diagnostic Research, 23, (2) pp. 191-207. ISSN 0741-238X (2006) [Refereed Article]

DOI: 10.1007/BF02850126 [eCite] [Details]

Citations: Scopus - 45Web of Science - 33

Tweet

2006Valentine WJ, Palmer AJ, Nicklasson L, Cobden D, Roze S, 'Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets', International Journal of Clinical Practice, 60, (9) pp. 1138-1145. ISSN 1368-5031 (2006) [Refereed Article]

DOI: 10.1111/j.1742-1241.2006.01102.x [eCite] [Details]

Citations: Scopus - 35Web of Science - 29

Tweet

2005Minshall ME, Roze S, Palmer AJ, Valentine WJ, Foos V, et al., 'Treating diabetes to accepted standards of care: a 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States', Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 27, (6) pp. 940-950. ISSN 0149-2918 (2005) [Refereed Article]

DOI: 10.1016/j.clinthera.2005.06.006 [eCite] [Details]

Citations: Scopus - 33Web of Science - 29

Tweet

2005Palmer AJ, 'Health economics--what the nephrologist should know', Nephrology, Dialysis and Transplantation, 20, (6) pp. 1038-1041. ISSN 0931-0509 (2005) [Contribution to Refereed Journal]

[eCite] [Details]

2005Palmer AJ, Annemans L, Roze S, Lapuerta P, Chen R, et al., 'Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria', Kidney International, 67, (Supplement 93) pp. S52-S54 . ISSN 0085-2538 (2005) [Refereed Article]

DOI: 10.1111/j.1523-1755.2005.09312.x [eCite] [Details]

Citations: Scopus - 16Web of Science - 18

Tweet

2005Palmer AJ, Tucker DMD, Ray JA, Valentine WJ, Currie C, et al., 'Insulin pumps: more consultation was needed', BMJ, 331, (7521) pp. 905-906. ISSN 0959-8146 (2005) [Letter or Note in Journal]

DOI: 10.1136/bmj.331.7521.905-c [eCite] [Details]

Citations: Web of Science - 1

Tweet

2005Palmer AJ, Tucker DMD, Valentine WJ, Roze S, Gabriel S, et al., 'Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies', Nephrology, Dialysis and Transplantation, 20, (6) pp. 1103-1109. ISSN 0931-0509 (2005) [Refereed Article]

DOI: 10.1093/ndt/gfh802 [eCite] [Details]

Citations: Scopus - 19Web of Science - 14

Tweet

2005Palmer AJ, Valentine WJ, Roze S, Lammert M, Spiesser J, et al., 'Overview of costs of stroke from published, incidence-based studies spanning 16 industrialized countries', Current Medical Research and Opinion, 21, (1) pp. 19-26. ISSN 0300-7995 (2005) [Refereed Article]

DOI: 10.1185/030079904X17992 [eCite] [Details]

Citations: Scopus - 38Web of Science - 35

Tweet

2005Poldrugo F, Haeger DA, Comte S, Walburg J, Palmer AJ, 'A critical review of pharmacoeconomic studies of acamprosate', Alcohol and Alcoholism, 40, (5) pp. 422-430. ISSN 0735-0414 (2005) [Refereed Article]

DOI: 10.1093/alcalc/agh171 [eCite] [Details]

Citations: Scopus - 14Web of Science - 11

Tweet

2005Ray JA, Valentine WJ, Secnik K, Oglesby AK, Cordony A, et al., 'Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain', Current Medical Research and Opinion, 21, (10) pp. 1617-1629. ISSN 0300-7995 (2005) [Refereed Article]

DOI: 10.1185/030079905X65349 [eCite] [Details]

Citations: Scopus - 100Web of Science - 91

Tweet

2005Roze S, Valentine WJ, Zakrzewska KE, Palmer AJ, 'Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK', Diabetic Medicine, 22, (9) pp. 1239-1245. ISSN 0742-3071 (2005) [Refereed Article]

DOI: 10.1111/j.1464-5491.2005.01576.x [eCite] [Details]

Citations: Scopus - 83Web of Science - 69

Tweet

2005Valentine WJ, Palmer AJ, Lammert M, Nicklasson L, Foos V, et al., 'Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naive type 2 diabetes patients: cost-effectiveness analysis in the UK setting', Current Medical Research and Opinion, 21, (12) pp. 2063-2071. ISSN 0300-7995 (2005) [Refereed Article]

DOI: 10.1185/030079905X74989 [eCite] [Details]

Citations: Scopus - 30Web of Science - 24

Tweet

2004Bergemann R, Brown J, Chan W, Clarke P, Eddy D, et al., 'Guidelines for computer modeling of diabetes and its complications', Diabetes Care, 27, (9) pp. 2262-2265. ISSN 0149-5992 (2004) [Refereed Article]

[eCite] [Details]

Citations: Web of Science - 169

2004Palmer AJ, Annemans L, Roze S, Lamotte A, Rodby RA, et al., 'Cost-effectiveness of Ibersartan in type II diabetic nephropathy with hypertension. A Spanish perspective', Nefrologia, 24, (3) pp. 231-238. ISSN 0211-6995 (2004) [Refereed Article]

[eCite] [Details]

Citations: Web of Science - 14

2004Palmer AJ, Annemans L, Roze S, Lamotte M, Lapuerta P, et al., 'Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease', Diabetes Care, 27, (8) pp. 1897-1903. ISSN 0149-5992 (2004) [Refereed Article]

DOI: 10.2337/diacare.27.8.1897 [eCite] [Details]

Citations: Scopus - 79Web of Science - 73

Tweet

2004Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, et al., 'An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting', Journal of Human Hypertension, 18, (10) pp. 733-738. ISSN 0950-9240 (2004) [Refereed Article]

DOI: 10.1038/sj.jhh.1001729 [eCite] [Details]

Citations: Scopus - 34Web of Science - 28

Tweet

2004Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, et al., 'Health economic consequences of irbesartan treatment of type 2 diabetes patients with nephropathy and hypertension in German', Deutsche Medizinische Wochenschrift, 129, (1-2) pp. 13-18. ISSN 0012-0472 (2004) [Refereed Article]

DOI: 10.1055/s-2004-812656 [eCite] [Details]

Citations: Scopus - 19Web of Science - 15

Tweet

2004Palmer AJ, Rodby RA, 'Health economics studies assessing irbesartan use in patients with hypertension, type 2 diabetes, and microalbuminuria', Kidney International. Supplement , (92) pp. S118-S120. ISSN 0098-6577 (2004) [Refereed Article]

[eCite] [Details]

2004Palmer AJ, Roze S, Lammert M, Valentine WJ, Minshall ME, et al., 'Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes', Current Medical Research and Opinion, 20, (Supplement 1) pp. S41-S51. ISSN 0300-7995 (2004) [Refereed Article]

DOI: 10.1185/030079904X2015 [eCite] [Details]

Citations: Scopus - 15Web of Science - 16

Tweet

2004Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, et al., 'The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making', Current Medical Research and Opinion, 20, (Supplement 1) pp. S5-S26. ISSN 0300-7995 (2004) [Refereed Article]

DOI: 10.1185/030079904X1980 [eCite] [Details]

Citations: Web of Science - 352

Tweet

2004Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, et al., 'Validation of the CORE Diabetes Model against epidemiological and clinical studies', Current Medical Research and Opinion, 20, (Supplement 1) pp. S27-S40. ISSN 0300-7995 (2004) [Refereed Article]

DOI: 10.1185/030079904X2006 [eCite] [Details]

Citations: Scopus - 254Web of Science - 213

Tweet

2004Palmer AJ, Roze S, Valentine WJ, Minshall ME, Hayes C, et al., 'Impact of changes in HbA1c, lipids and blood pressure on long-term outcomes in type 2 diabetes patients: an analysis using the CORE Diabetes Model', Current Medical Research and Opinion, 20, (1) pp. S53-S58. ISSN 0300-7995 (2004) [Refereed Article]

DOI: 10.1185/030079903125002611 [eCite] [Details]

Citations: Scopus - 36Web of Science - 31

Tweet

2004Palmer AJ, Roze S, Valentine WJ, Minshall ME, Lammert M, et al., 'What impact would pancreatic beta-cell preservation have on life expectancy, quality-adjusted life expectancy and costs of complications in patients with type 2 diabetes? A projection using the CORE Diabetes Model', Current Medical Research and Opinion, 20, (1) pp. S59-S66. ISSN 0300-7995 (2004) [Refereed Article]

DOI: 10.1185/030079904X2024 [eCite] [Details]

Citations: Web of Science - 12

Tweet

2004Palmer AJ, Roze S, Valentine WJ, Minshall ME, Lammert M, et al., 'Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy', Current Medical Research and Opinion, 20, (Supplement 1) pp. S67-S73. ISSN 0300-7995 (2004) [Refereed Article]

DOI: 10.1185/030079904X2033 [eCite] [Details]

Citations: Web of Science - 12

Tweet

2004Palmer AJ, Roze S, Valentine WJ, Smith I, Wittrup-Jensen KU, 'Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials', Current Medical Research and Opinion, 20, (11) pp. 1729-1746 . ISSN 0300-7995 (2004) [Refereed Article]

DOI: 10.1185/030079904X5661 [eCite] [Details]

Citations: Scopus - 40Web of Science - 28

Tweet

2004Palmer AJ, Roze S, Valentine WJ, Spinas G, 'The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes: response to Scuffham [corrected] and Carr', Diabetic Medicine, 21, (12) pp. 1372-1372. ISSN 0742-3071 (2004) [Letter or Note in Journal]

DOI: 10.1111/j.1464-5491.2004.1349a.x [eCite] [Details]

Citations: Web of Science - 3

Tweet

2004Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, et al., 'Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom', Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 26, (2) pp. 304-321. ISSN 0149-2918 (2004) [Refereed Article]

DOI: 10.1016/S0149-2918(04)90029-X [eCite] [Details]

Citations: Scopus - 107Web of Science - 88

Tweet

2003Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, et al., 'An Economic Evaluation of Irbesartan in the Treatment of Patients with Type 2 Diabetes, Hypertension and Nephropathy: Cost-Effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French Settings', Nephrology, Dialysis and Transplantation, 18, (10) pp. 2059-2066. ISSN 0931-0509 (2003) [Refereed Article]

DOI: 10.1093/ndt/gfg232 [eCite] [Details]

Citations: Scopus - 50Web of Science - 41

Tweet

2003Rodby RA, Chiou CF, Borenstein J, Smitten A, Sengupta N, et al., 'The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy', Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 25, (7) pp. 2102-2119 . ISSN 0149-2918 (2003) [Refereed Article]

DOI: 10.1016/S0149-2918(03)80208-4 [eCite] [Details]

Citations: Scopus - 50Web of Science - 45

Tweet

2003Roze S, Palmer AJ, Valentine WJ, 'A multivariate logistic regression equation to screen for diabetes: response to Tabaei and Herman', Diabetes Care, 26, (5) pp. 1658-1659. ISSN 0149-5992 (2003) [Letter or Note in Journal]

DOI: 10.2337/diacare.26.5.1658 [eCite] [Details]

Citations: Scopus - 2Web of Science - 3

Tweet

2002Coyle D, Palmer AJ, Tam R, 'Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in Canada', Pharmacoeconomics, 20, (Supplement 1) pp. 31-42. ISSN 1170-7690 (2002) [Refereed Article]

DOI: 10.2165/00019053-200220001-00004 [eCite] [Details]

Citations: Web of Science - 25

Tweet

2002Sendi P, Palmer AJ, Hauri P, Craig BA, Horber FF, 'Modeling the impact of adjustable gastric banding on survival in patients with morbid obesity', Obesity Research, 10, (4) pp. 291-295. ISSN 1071-7323 (2002) [Refereed Article]

DOI: 10.1038/oby.2002.40 [eCite] [Details]

Citations: Scopus - 4Web of Science - 4

Tweet

2001Gozzoli V, Palmer AJ, Brandt A, Spinas GA, 'Economic and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss setting ', Swiss Medical Weekly, 131, (21-22) pp. 303-310. ISSN 1424-7860 (2001) [Refereed Article]

[eCite] [Details]

Citations: Web of Science - 22

2001Gozzoli V, Palmer AJ, Brandt A, Weiss C, Piehlmeier W, et al., 'Increased clinical and economic advantage of proteinuric screening and intervention (PROSIT project) in type 2 diabetics', Deutsche Medizinische Wochenschrift, 125, (39) pp. 1154-1159. ISSN 0012-0472 (2001) [Refereed Article]

DOI: 10.1055/s-2000-7670 [eCite] [Details]

Citations: Scopus - 20Web of Science - 15

Tweet

2001Palmer AJ, 'Commentary: Intensive glucose control is more costly than conventional treatment but also has more benefits for people with type-2 diabetes', Evidence - Based Healthcare and Public Health, 5, (1) pp. 17-18. ISSN 1744-2249 (2001) [Contribution to Refereed Journal]

DOI: 10.1054/ebhc.2000.0376 [eCite] [Details]

Tweet

2001Palmer AJ, Sendi PP, 'New aspects in health economic studies of prevention and treatment of osteoporosis', Expert Review of Pharmacoeconomics & Outcomes Research, 1, (2) pp. 198-204. ISSN 1744-8379 (2001) [Refereed Article]

DOI: 10.1586/14737167.1.2.198 [eCite] [Details]

Tweet

2001Sendi P, Palmer AJ, Gafni A, Battegay M, 'Highly Active Antiretroviral Therapy: Pharmacoeconomic issues in the management of HIV infection', Pharmacoeconomics, 19, (7) pp. 709-713. ISSN 1170-7690 (2001) [Refereed Article]

DOI: 10.2165/00019053-200119070-00001 [eCite] [Details]

Citations: Scopus - 29Web of Science - 25

Tweet

2000Brown JB, Palmer AJ, Bisgaard P, Chan W, Pedula K, et al., 'The Mt. Hood Challenge: cross-testing two diabetes simulation models', Diabetes Research and Clinical Practice, 50, (Supplement 3) pp. S57-S64. ISSN 0168-8227 (2000) [Refereed Article]

DOI: 10.1016/S0168-8227(00)00217-5 [eCite] [Details]

Citations: Web of Science - 56

Tweet

2000Palmer AJ, Brandt A, Gozzoli V, Weiss C, Stock H, et al., 'Outline of a diabetes disease management model: principles and applications', Diabetes Research and Clinical Practice, 50, (Supplement 3) pp. S47-S56. ISSN 0168-8227 (2000) [Refereed Article]

DOI: 10.1016/S0168-8227(00)00216-3 [eCite] [Details]

Citations: Web of Science - 28

Tweet

2000Palmer AJ, Neeser K, Weiss C, Brandt A, Comte S, et al., 'The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate', Alcohol and Alcoholism, 35, (5) pp. 478-492. ISSN 0735-0414 (2000) [Refereed Article]

DOI: 10.1093/alcalc/35.5.478 [eCite] [Details]

Citations: Web of Science - 38

Tweet

2000Palmer AJ, Sendi PP, Spinas GA, 'Applying some UK Prospective Diabetes Study results to Switzerland: The cost-effectiveness of intensive glycemic control with metformin versus conventional control in overweight patients with type 2 diabetes', Schweizerische Medizinische Wochenschrift, 130, (27-28) pp. 1034-1040. ISSN 0036-7672 (2000) [Refereed Article]

[eCite] [Details]

Citations: Web of Science - 20

2000Palmer AJ, Weiss C, Sendi PP, Neeser K, Brandt A, et al., 'The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective', Diabetologia: Clinical and Experimental Diabetes and Metabolism, 43, (1) pp. 13-26. ISSN 0012-186X (2000) [Refereed Article]

DOI: 10.1007/s001250050003 [eCite] [Details]

Citations: Scopus - 87Web of Science - 72

Tweet

2000Sendi P, Palmer AJ, 'Modeling the socioeconomic impact of osteoporosis-related hip fractures in Switzerland', Osteoporosis International, 11, (1) pp. 92-94 . ISSN 0937-941X (2000) [Refereed Article]

DOI: 10.1007/s001980050011 [eCite] [Details]

Citations: Scopus - 6Web of Science - 6

Tweet

1999Palmer AJ, Sendi PP, 'Meta-analysis in oral health care', Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 87, (2) pp. 135-141. ISSN 1079-2104 (1999) [Refereed Article]

DOI: 10.1016/S1079-2104(99)70262-3 [eCite] [Details]

Citations: Scopus - 8Web of Science - 7

Tweet

1999Sendi PP, Palmer AJ, Marinello CP, 'Some principles of cost-effectiveness analysis in dentistry', Acta Medicinae Dentium Helvetica, 4, (4) pp. 63-67. ISSN 1420-8873 (1999) [Refereed Article]

[eCite] [Details]

1998Neeser K, Brandt A, Palmer AJ, Volz A, 'Gesundheitsoekonomische Auswirkungen der Algodystrophie unter Einbezug von Calcitonin [Health economic effects of calcitonin on algodystrophy]', Managed Care (Switzerland), 1, (6) pp. 39-43. ISSN 1422-6618 (1998) [Refereed Article]

[eCite] [Details]

1998Palmer AJ, Neeser K, Paschen B, Cleland JGF, 'Economic implications of the Total Ischemic Burden Bisoprolol Study (TIBBS) follow-up', Journal of Medical Economics , 1, (1-4) pp. 263-280. ISSN 1941-837X (1998) [Refereed Article]

DOI: 10.3111/199801263280 [eCite] [Details]

Citations: Scopus - 2

Tweet

1997Kirchhof B, Palmer AJ, Kakkar VV, Bergemann R, 'The Economic Burden of Deep Vein Thrombosis Sequelae: A Cost of Illness Analysis for Germany', Gesundheitsoekonomie und Qualitaetsmanagement , 2 pp. 40-44. ISSN 1439-4049 (1997) [Refereed Article]

[eCite] [Details]

1997Palmer AJ, Brandt A, 'The cost-effectiveness of gemcitabine plus cisplatin chemotherapy versus mitomycin ifosfamide and cisplatin (MIP), etopiside plus cisplatin, and vinorelbine plus cisplatin in the treatment of stages III B and IV non-small cell lung cancer: An Italian perspective (letter)', Monaldi Archives for Chest Disease, 52, (3) pp. 305-306. ISSN 1122-0643 (1997) [Letter or Note in Journal]

[eCite] [Details]

1997Palmer AJ, Koppenhagen K, Kirchhof B, Weber U, Bergemann R, 'Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thromboembolism prophylaxis in orthopaedic surgery: A meta-analysis of randomised clinical trials', Haemostasis, 27, (2) pp. 75-84. ISSN 0301-0147 (1997) [Refereed Article]

[eCite] [Details]

Citations: Web of Science - 75

1997Palmer AJ, Schramm W, Kirchhof B, Bergemann R, 'Low Molecular Weight Heparin for Prevention of Thromboembolism in General Surgery: A Meta-Analysis of Randomized Clinical Trials with Low Molecular Weight Heparin, Unfractionated Heparin, and Warfarin', Haemostasis, 27, (2) pp. 65-74. ISSN 0301-0147 (1997) [Refereed Article]

[eCite] [Details]

Citations: Web of Science - 57

1997Sendi PP, Palmer AJ, Marinello CP, 'Health State Utilities in Dentistry: A Review', Acta Medicinae Dentium Helvetica, 2, (10) pp. 243-248. ISSN 1420-8873 (1997) [Refereed Article]

[eCite] [Details]

1996Palmer AJ, Brandt A, 'The cost-effectiveness of gemcitabine plus cisplatin chemotherapy versus mitomycin ifosfamide and cisplatin (MIP), etopiside plus cisplatin, and vinorelbine plus cisplatin in the treatment of stages III B and IV non-small cell lung cancer: An Italian perspective', Monaldi Archives for Chest Disease, 51, (4) pp. 279-288. ISSN 1122-0643 (1996) [Refereed Article]

[eCite] [Details]

Chapter in Book

(2 outputs)
YearCitationAltmetrics
2020Borchers N, Bowman DMJS, Palmer AJ, Johnston FH, 'Climate Change, Wildfires, Heatwaves and Health Impacts in Australia', Extreme Weather Events and Human Health, Springer, R Akhtar (ed), Cham, Switzerland, pp. 99-116. ISBN 978-3-030-23772-1 (2020) [Research Book Chapter]

DOI: 10.1007/978-3-030-23773-8_8 [eCite] [Details]

Citations: Scopus - 21

Co-authors: Borchers N; Bowman DMJS; Johnston FH

Tweet

2014Si L, Palmer AJ, 'Prevention of T2DM: health economics', Diapedia. The living textbook of diabetes., R. Landgraf (ed) (2014) [Other Book Chapter]

DOI: 10.14496/dia.0104770156.4 [eCite] [Details]

Co-authors: Si L

Tweet

Review

(3 outputs)
YearCitationAltmetrics
2022Dinh NTT, Cox IA, de Graaff B, Campbell JA, Stokes BC, et al., 'A comprehensive systematic review of data linkage publications on diabetes in Australia', Frontiers in Public Health, 10 pp. 757987. ISSN 2296-2565 (2022) [Substantial Review]

DOI: 10.3389/fpubh.2022.757987 [eCite] [Details]

Co-authors: Dinh NTT; Cox IA; de Graaff B; Campbell JA; Stokes BC

Tweet

2012Liebl A, Prusty V, Valensi P, Kawamori R, Christiansen JS, et al., 'Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings', Drugs, 72, (11) pp. 1495-1520. ISSN 0012-6667 (2012) [Substantial Review]

DOI: 10.2165/11635490-000000000-00000 [eCite] [Details]

Citations: Scopus - 30Web of Science - 25

Tweet

2011Tucker DMD, Palmer AJ, 'The cost-effectiveness of interventions in diabetes: A review of published economic evaluations in the UK setting, with an eye on the future', Primary Care Diabetes, 5, (1) pp. 9-17. (2011) [Substantial Review]

DOI: 10.1016/j.pcd.2010.10.001 [eCite] [Details]

Citations: Scopus - 8Web of Science - 6

Co-authors: Tucker DMD

Tweet

Conference Publication

(27 outputs)
YearCitationAltmetrics
2022Campbell JA, Ahmad H, Chen G, Claflin S, Taylor BV, et al., 'Investigating health-related quality of life impacts for participants of the Australian MS Longitudinal Study using the new EQ-5D-5L Psychosocial instrument', Multiple Sclerosis Journal, pp. 18-19. ISSN 1352-4585 (2022) [Conference Extract]

[eCite] [Details]

Co-authors: Campbell JA; Ahmad H; Claflin S; Taylor BV; van der Mei I; Laslett L; Henson G

2022Campbell JA, Ahmad H, Claflin S, Taylor BV, van der Mei I, et al., 'Assessing health-related quality-of-life in Australian Multiple Sclerosis Longitudinal Study participants using six multi-attribute utility instruments: implications for healthcare decision-making', Multiple Sclerosis Journal, pp. 19. ISSN 1352-4585 (2022) [Conference Extract]

[eCite] [Details]

Co-authors: Campbell JA; Ahmad H; Claflin S; Taylor BV; van der Mei I; Laslett L; Henson G

2022Claflin S, Campbell J, Bessing B, van der Mei I, Palmer AJ, et al., 'Knowledge translation in the international MS community: an evaluation of the Understanding Multiple Sclerosis free online course', Multiple Sclerosis Journal, pp. 19. ISSN 1352-4585 (2022) [Conference Extract]

[eCite] [Details]

Co-authors: Claflin S; Campbell J; Bessing B; van der Mei I; Taylor BV

2022Cox I, Campbell JA, de Graaff B, Corte TJ, Moodley Y, et al., 'P50 Comparison of the EQ-5D-5L and Aqol-8D in a cohort of people with idiopathic pulmonary fibrosis in Australia', The Future of HEOR in Patient-Driven Digital Healthcare Systems, 15-18 May 2022, Washington D.C, pp. S298. ISSN 1524-4733 (2022) [Conference Extract]

DOI: 10.1016/j.jval.2022.04.065 [eCite] [Details]

Co-authors: Cox I; Campbell JA; de Graaff B; Walter HE

Tweet

2022Cox I, de Graaff B, Ahmad H, Campbell JA, Otahal P, et al., 'P43 The economic burden of idiopathic pulmonary fibrosis in Australia', The Future of HEOR in Patient-Driven Digital Healthcare Systems, 15-18 May 2022, Washington D.C, pp. S296. ISSN 1524-4733 (2022) [Conference Extract]

DOI: 10.1016/j.jval.2022.04.056 [eCite] [Details]

Co-authors: Cox I; de Graaff B; Ahmad H; Campbell JA; Otahal P; Walter HE

Tweet

2022Dinh NTT, de Graaff B, Campbell JA, Jose MD, Burgess J, et al., 'Costs of major complications in people with and without diabetes in Tasmania, Australia', Abstracts of the 58th EASD Annual Meeting, 19-23 September 2022, Stockholm, Sweden, pp. 1-2. ISSN 1432-0428 (2022) [Conference Extract]

DOI: 10.1007/s00125-022-05755-w [eCite] [Details]

Citations: Scopus - 1

Co-authors: Dinh NTT; de Graaff B; Campbell JA; Jose MD; Burgess J; Saunder T; Kitsos A; Wiggins Nadine

Tweet

2022Dinh Thi Thu Ngan, de Graaff B, Campbell JA, Jose MD, Burgess John, et al., 'EPH31 Risk of hospital admission or emergency department presentation due to diabetes complications: A retrospective cohort study in Tasmania, Australia', ISPOR Europe 2022 Abstracts, Values in Health Supplement, November 6-9, 2022, Vienna, Austria, pp. 197. ISSN 1098-3015 (2022) [Conference Extract]

DOI: 10.1016/j.jval.2022.09.953 [eCite] [Details]

Co-authors: Dinh Thi Thu Ngan; de Graaff B; Campbell JA; Jose MD; Burgess John; Saunder THC; Kitsos AR; Otahal P

Tweet

2022Dinh Thi Thu Ngan, de Graaff B, Campbell JA, Palmer AJ, 'P55 Creating a web-based interactive map visualising the geographic variations of the burden of Diabetes to inform policymaking: an example from Tasmania, Australia', ISPOR Europe 2022 Abstracts, Values in Health Supplement, November 6-9, 2022, Vienna, Austria, pp. 13. ISSN 1098-3015 (2022) [Conference Extract]

DOI: 10.1016/j.jval.2022.09.067 [eCite] [Details]

Co-authors: Dinh Thi Thu Ngan; de Graaff B; Campbell JA

Tweet

2022Henson G, van der Mei I, Taylor B, Blacklow P, Claflin SB, et al., 'The impact of the COVID-19 pandemic and lockdowns on the health-related quality of life of people living with multiple sclerosis in Australia', Value in Health, July 2022 ISSN 1098-3015 (2022) [Conference Extract]

[eCite] [Details]

Co-authors: Henson G; van der Mei I; Taylor B; Blacklow P; Claflin SB; Hurst C; Campbell JA

2021Cox IA, de Graaff B, Corte TJ, Glaspole I, Chambers DC, et al., 'Thoracic Society of Australia and New Zealand Annual Scientific Meeting 2021', Thoracic Society of Australia and New Zealand Annual Scientific Meeting 2021, 1 -2 May 2021, virtual, pp. 1-8. (2021) [Conference Extract]

[eCite] [Details]

Co-authors: Cox IA; de Graaff B; Walters EH

2021Singh A, Campbell J, Venn A, Jones G, Blizzard L, et al., 'Association between knee symptoms, change in knee symptoms over 6-9 years, and SF-6D health state utility among middle-aged Australians', Value in Health, pp. S139. ISSN 1098-3015 (2021) [Conference Extract]

[eCite] [Details]

Co-authors: Singh A; Campbell J; Venn A; Jones G; Blizzard L; Ding C; Antony B

2021Xia Q, Campbell J, Ahmad H, de Graaff B, Si L, et al., 'Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system', Value in Health ISSN 1098-3015 (2021) [Conference Extract]

DOI: 10.1016/j.jval.2021.04.1130 [eCite] [Details]

Co-authors: Xia Q; Campbell J; Ahmad H; de Graaff B; Otahal P

Tweet

2020Black JA, Sharman J, Palmer A, de Graaff B, Hensher M, et al., 'Quality of life improves more for people who receive proactive absolute', Value in Health Regional Issues ISSN 2212-1099 (2020) [Conference Extract]

[eCite] [Details]

Co-authors: Sharman J; de Graaff B; Otahal P; Nelson M; Campbell J

2020Cox I, Borchers Arriagada N, de Graaff B, Corte T, Glaspole I, et al., 'Evaluation of health-related quality of life in IPF: A systematic review and meta-analysis', Respirology ISSN 1323-7799 (2020) [Conference Extract]

[eCite] [Details]

Co-authors: Cox I; Borchers Arriagada N; de Graaff B; Lartey S; Walters H

2020Cox I, de Graaff B, Ahmad H, Corte TJ, Walters HE, et al., 'The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia', Value in Health Regional Issues ISSN 2212-1099 (2020) [Conference Extract]

[eCite] [Details]

Co-authors: Cox I; de Graaff B; Ahmad H; Walters HE

2018Campbell JA, Ezzy D, Neil A, Hensher M, Venn A, et al., 'PCP4 A qualitative investigation of information asymmetry for obesity surgery: Diversity of patient experiences in the information age and demand-induced supply', Value in Health, pp. S23, Vol 21. ISSN 1098-3015 (2018) [Conference Extract]

[eCite] [Details]

Co-authors: Campbell JA; Ezzy D; Neil A; Venn A; Sharman M

2018Campbell JA, Hensher M, Davies D, Green M, Hagan B, et al., 'PSY33 A Cost-Outcome Study: A real-world investigation of long-term inpatient hospital utilisation and costs for a retrospective cohort of bariatric surgery patients in an Australian public hospital system based on Australia's activity based funding model', Value in Health, pp. S111, Vol 21. ISSN 1098-3015 (2018) [Conference Extract]

[eCite] [Details]

Co-authors: Campbell JA; Venn A; Kuzminov A; Neil A

2018Lartey ST, Ahmad H, Si L, de Graaff B, Magnussen CG, et al., 'Health state utilities and high body mass index: evidence from WHO study of global ageing and adult health (SAGE)', Value in Health, pp. S109 (PSY20). (2018) [Conference Extract]

[eCite] [Details]

Co-authors: Lartey ST; Ahmad H; Si L; de Graaff B; Magnussen CG

2016Ahmad H, van der Mei I, Taylor B, Palmer AJ, 'PND13 - Assessing Health-State Utility Values in Australian People with Multiple Sclerosis', Value in Health, pp. A875, 19 (7). (2016) [Conference Extract]

DOI: 10.1016/j.jval.2016.08.342 [eCite] [Details]

Co-authors: Ahmad H; van der Mei I; Taylor B

Tweet

2016Campbell JA, Hensher M, Venn A, Neil A, Otahal P, et al., 'PSY15 A unique opportunity to assess quality-of-life changes in long-term waitlisted bariatric surgery patients using the EQ-5D-5L and AQOL-8D multi-attribute utility instruments before and three months after bariatric surgery: an exploratory study', Value in Health, pp. A882, Vol 19. ISSN 1098-3015 (2016) [Conference Extract]

[eCite] [Details]

Co-authors: Campbell JA; Venn A; Neil A; Otahal P

2016Palmer AJ, Taylor B, Van der Mei I, Si L, Ahmad H, 'CU3 - Life Expectancy, Quality-Adjusted Life Years, and Total Lifetime Costs for Australian People with Multiple Sclerosis', Value in Health, pp. A808, 19 (7). (2016) [Conference Extract]

DOI: 10.1016/j.jval.2016.08.722 [eCite] [Details]

Co-authors: Taylor B; Van der Mei I; Si L; Ahmad H

Tweet

2016Walters H, Tierney L, Annear M, Elliott KJ, Palmer A, et al., 'Assessment and management of chronic respiratory conditions in frail older adults', Respirology, pp. 145, 21 (2). ISSN 1323-7799 (2016) [Conference Extract]

DOI: 10.1111/resp.12755 [eCite] [Details]

Co-authors: Walters H; Tierney L; Annear M; Elliott KJ; Robinson A

Tweet

2016de Graaff BL, Neil A, Sanderson K, Yee KC, Palmer AJ, 'PND9 - An Australian National Cost of Illness Study For Hereditary Haemochromatosis', Value in Health, pp. A874, 19 (7). ISSN 1098-3015 (2016) [Conference Extract]

DOI: 10.1016/j.jval.2016.08.344 [eCite] [Details]

Co-authors: de Graaff BL; Neil A; Sanderson K; Yee KC

Tweet

2016de Graaff BL, Si L, Neil A, Yee KC, Sanderson K, et al., 'PND10 - Cost-Effectiveness of Population Screening for Haemochromatosis In Australia: A State-Transition Model', Value in Health, pp. A874-A875, Vol 19 (7). ISSN 1098-3015 (2016) [Conference Extract]

DOI: 10.1016/j.jval.2016.08.345 [eCite] [Details]

Co-authors: de Graaff BL; Si L; Neil A; Yee KC; Sanderson K

Tweet

2015de Graaff BL, Neil A, Sanderson K, Yee KC, Palmer A, 'The impact of increasing severity of hereditary haemochromatosis on health state utility values', Value in Health, pp. A300, Vol 18, A1-A307. ISSN 1098-3015 (2015) [Conference Extract]

[eCite] [Details]

Co-authors: de Graaff BL; Neil A; Sanderson K; Yee KC

2014McKercher C, Venn A, Blizzard CL, Nelson M, Palmer AJ, et al., 'Psychosocial factors in chronic kidney disease: 2 year follow-up of pilot participants', Nephrology, pp. 17-57, 19 (Supp 4). ISSN 1320-5358 (2014) [Conference Extract]

[eCite] [Details]

Co-authors: McKercher C; Venn A; Blizzard CL; Nelson M; Ashby M; Scott J; Jose MD

2013Elliott K-E, Annear MJ, Bell EJ, Palmer AJ, Robinson AL, 'Dementia tsunami in aged care: can students improve residents' quality of life?', The 46th Australian Association of Gerontology National Conference, 27-29 Nov, Sydeny, NSW (2013) [Conference Extract]

[eCite] [Details]

Co-authors: Elliott K-E; Annear MJ; Bell EJ; Robinson AL

Contract Report, Consultant's Report

(3 outputs)
YearCitationAltmetrics
2023Campbell J, van der Mei I, Taylor B, Palmer A, 'Health Economic Impact of Multiple Sclerosis in Australia in 2021: An Interim Update of Prevalence, Costs and Cost of Illness from 2017 to 2021', Multiple Sclerosis Australia, Hobart, Australia (2023) [Contract Report]

[eCite] [Details]

Co-authors: Campbell J; van der Mei I; Taylor B

2018Ahmad H, Campbell JA, van der Mei I, Taylor B, Palmer AJ, 'Health Economic Impact of Multiple Sclerosis in Australia in 2017: An analysis of MS Research Australia's platform - the Australian MS Longitudinal Study (AMSLS)', Multiple Sclerosis Research Australia (2018) [Contract Report]

[eCite] [Details]

Co-authors: Ahmad H; Campbell JA; van der Mei I; Taylor B

2011Palmer AJ, 'Economic Impact of Multiple Sclerosis in 2010: Australian MS Longitudinal Study', Multiple Sclerosis Research Australia (2011) [Consultants Report]

[eCite] [Details]

Other Public Output

(6 outputs)
YearCitationAltmetrics
2019Doherty B, Nash R, Elmer S, Campbell J, Julian R, et al., 'Lead Support Coordinator Service (LSCS) Evaluation Report', Prepared for the Department of Communities, Tasmania, Australia (2019) [Report of Restricted Access]

[eCite] [Details]

Co-authors: Doherty B; Nash R; Elmer S; Campbell J; Julian R; Vandenberg M; West S; de Graaff B

2017Ahmad H, Palmer AJ, van der Mei I, Taylor B, 'A sub-group analysis of the Australian Multiple Sclerosis Longitudinal Study (AMSLS) assessing costs and utility in Primary Progressive Multiple Sclerosis (PPMS) patients', Roche Australia, pp. 1-28. (2017) [Government or Industry Research]

[eCite] [Details]

Co-authors: Ahmad H; van der Mei I; Taylor B

2016Neil A, de Graaff B, Chappell K, Sanderson K, Palmer A, et al., 'What Value GP Assist? The comparative benefits of, and satisfaction with GP Assist in Residential Aged Care Facilities and General Practice in Rural and Urban Tasmania', Department of Health and Human Services, Tasmanian Government, Tasmania (2016) [Report of Restricted Access]

[eCite] [Details]

Co-authors: Neil A; de Graaff B; Chappell K; Sanderson K; Nelson M

2016Neil A, de Graaff B, Nelson M, Chappell K, Palmer A, et al., 'Tasmanian After-Hours Primary Care Service Innovations: A Report in Three Parts', Primary Health Tasmania, Australia (2016) [Report of Restricted Access]

[eCite] [Details]

Co-authors: Neil A; de Graaff B; Nelson M; Chappell K; Sanderson K

2015Neil A, Nelson M, Sanderson K, Palmer A, 'Improving the availability and efficiency of appropriate urgent service provision in Tasmania: Interim evaluation of the GP Assist and the Tasmanian General Practice After-Hours Incentive Funding Model 2014-15', Tasmania Medicare Local, Tasmania (2015) [Report of Restricted Access]

[eCite] [Details]

Co-authors: Neil A; Nelson M; Sanderson K

2014Neil A, Nelson M, Palmer AJ, 'General Practice After Hours Practice Funding: 2014-15 Funding Model', Tasmania Medicare Local, Australia (2014) [Report of Restricted Access]

[eCite] [Details]

Co-authors: Neil A; Nelson M

Grants & Funding

Funding Summary

Number of grants

53

Total funding

$33,338,141

Projects

Improving outcomes for Tasmanians diagnosed with lung cancer (2024 - 2026)$449,997
Description
This project driven by clinicians concerns regarding delays experienced by lung cancer patients. Tasmanian lung cancer patients experience some of the worst outcomes nationally. Timely diagnosis and treatment can improve survival and quality of life. To address this, we will investigate patient and service delivery factors that influence outcomes with the aim of co-designing and piloting strategies to improve the outcomes for Tasmanians diagnosed with lung cancer
Funding
Royal Hobart Hospital Research Foundation ($449,997)
Scheme
Grant-Major Project
Administered By
University of Tasmania
Research Team
Cox IA; Harkness N; Van Dam PJ; Palmer AJ; de Graaff B; Otahal P; Hensher M; Grundy R; Ball E; Black A; Witherden E; Sohal SS
Period
2024 - 2026
Economic Impact report 2023 (2023 - 2025)$184,175
Description
To produce a Report on the Economic Impact of MS in Australia in that:A brief overview of MSPrevalence of MSHealthcare costs and indirect costs (including lost productivity)Quality of life for those affected by MS
Funding
Multiple Sclerosis Australia ($184,175)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Palmer AJ; Campbell JA; Taylor BVM; Zhao T
Period
2023 - 2025
CRE for Pulmonary Fibrosis - towards individualised care (2023 - 2027)$2,500,000
Description
Interstitial lung disease (ILD) encompasses a group of lung disorders characterised by fibrosis of the lung tissue. Typically ILD patients experience significant impacts on quality of life, and effective treatments are lacking. The most common form idiopathic pulmonary fibrosis is also the most serious with a life expectancy of 2-5 years. This team is at the forefront of international developments prompting a new and individualised approach to care of patients with ILD. Recent advances show there are common underlying genetic and biological pathways, and new anti-fibrotic medications are effective across the whole ILD spectrum. In this CRE-ILD, we bring together a new multidisciplinary, diverse team from across Australia, to address patient-identified research priorities.
Funding
National Health & Medical Research Council ($2,500,000)
Scheme
Grant-Centre of Research Excellence
Administered By
University of Sydney
Research Team
Corte T; Holland A; Chambers D; Hansbro P; Dickinson JL; Palmer AJ; Moodley Y; Powell J
Period
2023 - 2027
Grant Reference
2015613
A randomised clinical trial of a digital self-management package for people with Interstitial Lung Disease (the REBUILD-SM trial) (2023 - 2024)$1,999,997
Description
Interstitial lung disease (ILD) encompasses a group of lung disorders characterised by fibrosis of the lung tissue. Whilst twonew antifibrotic drugs slow th";􀁿.ration of progressive ILD, there is unmet need for treatments to improve health-related quality of life (HRQoL).Research priorities identified by people living with ILD include treatments to improve HRQoL, and ILD-specific interventions to support selfmanagement.Recent data show the important role of self-management to improve outcomes for patients with other lung diseases, with resultant improved HRQoL,but its role in ILD is yet unstudied.Our team has developed a world-first, evidence based, ILD-specific self-management package in partnership with patients and clinicians. We have alsodeveloped and tested the RE-BUILD (Registry for Better Understanding of ILD) smartphone application, linked to the Australasian IL,D registry. We willnow integrate the ILD-specific self-management package with our RE-BUILD app to form REBUILD-SM, and intervention with improved reach anddelivery.We hypothesise that REBUILD-SM will improve HRQoL for people living with ILD, through better self-efficacy and reduced symptom burden andanxiety, leading to reduced health care utilisation.Our expert multi-disciplinary team will evaluate the efficacy and cost-effectiveness of the technology-delivered intervention in a randomised clinicaltrial.Aim 1. To compare the clinical efficacy of REBUILD-SM versus standard care in people with ILD.Aim 2. To compare the cost-effectiveness of REBUILD-SM versus standard care in people with ILD.Aim 3. To understand barriers and facilitators for adoption of REBUILD-SM by people with ILD and health professionals to underpin futureimplementation and drive uptake for clinical practice. This world-first study will provide the high-quality evidence needed to drive uptake of this digitalself-management intervention, and ultimately improve best practice care for people with ILD across Australia.
Funding
Medical Research Future Fund ($1,999,997)
Scheme
Grant - Chronic Respiratory Conditions
Administered By
University of Tasmania
Research Team
Corte T; Palmer AJ; Cox IA
Period
2023 - 2024
Evaluation of the extended School Lunch Pilot (2022 - 2023)$65,000
Description
This project will conduct an evaluation of the 2022-23 Tasmanian State Government funded school lunch pilot to:* identify the benefits and challenges of providing a school lunch program;* estimate the costs of providing a school lunch program;* examine associations between the school lunch program and school attendance, student wellbeing and academicperformance.Data will be collected from at least six schools using a combination of quantitative and qualitative methods. Feedback will be obtainedfrom key stakeholders (students, parents, food service staff and volunteers, school staff).
Funding
School Food Matters ($65,000)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Smith KJ; Jose KA; Cleland V; Palmer AJ
Period
2022 - 2023
Prevalence and economic cost of multiple sclerosis in Australia 2022 (2022)$20,000
Description
A quick update of prevalence and costs of MS in 2022, at the request of MS Australia who contacted me a couple of days ago with money to spend before the EOFY.We will:A) Use the methods described in Palmer et al1 and Campbell et al2 to give an updated estimate of the 2021/22 prevalence of MSB) Use inflation rates to update the total costs from the Health Economic Impact of Multiple Sclerosis in Australia 2017 report to 2021/22 valuesC) Provide a preliminary written report of not less than 5 pages, including an executive summary, that details the methods used and the results of A and B.D) Included one round of revisions following review by MS Australia of preliminary report E) Deliver final report in electronic formBudget:$20,000Timelines:Work to commence July 1, 2022Preliminary report delivered to MS Australia by September 15thRevisions to be provided by MS Australia by end September 2022Final report delivered by October 15, 2022.
Funding
Multiple Sclerosis Australia ($20,000)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Palmer AJ; Campbell JA
Year
2022
The health economic impacts of residential fires on the Tasmanian public healthcare system 2010 to 2020 using a mixed-methods approach (2022)$9,945
Description
This is the first collaboration between the Tasmanian Fire Service and the Menzies Institute for Medical Research. Using linked data, this project will investigate epidemiological profiles and health services utilisation regarding residential house fires in Tasmania from 2010 to 2020.
Funding
Royal Hobart Hospital Research Foundation ($9,945)
Scheme
Grant-Incubator
Administered By
University of Tasmania
Research Team
Dinh T; Campbell JA; Palmer AJ; Schrale RB; Ratcliffe K; Orr F; King L; Barber S; de Graaff B
Year
2022
Eliminating hepatitis B in remote Indigenous settings: generating health economic evidence (2022 - 2025)$750,738
Description
Chronic hepatitis B (CHB) is endemic across Indigenous communities in the Northern Territory (NT), with prevalence between 2-5%. Of this group, up to 25% will die from decompensated cirrhosis or liver cancer without care and treatment. In turn, liver disease is the third leading factor contributing to the gap in life expectancy between Indigenous and non-Indigenous Australians.In 2017 the NHMRC funded the Hep B PAST Partnership Project (GNT1151837), which aims to eliminate CHB from NT Indigenous Australians. This is being achieved through two mechanisms: improvement of CHB health literacy amongst participating Indigenous communities and healthcare providers; and transition of CHB care to a primary healthcare based, co-ordinated chronic disease model supported by the establishment of a CHB clinical register.The preliminary results of the Hep B PAST Project have demonstrated a highly effective model of care to increase rates of CHB diagnosis, treatment and community education. The Hep B PAST Project will be completed in mid-2023. To successfully eliminate hepatitis B, it is now critically important to transition this care model Territory-wide. Health economic evidence is now required by government to support this. We have developed five studies to generate this evidence:1: Quantify costs of the Hep B PAST model of care and the status quo approach to CHB care;2: Quantify quality of life/health state utility values for hepatitis B health states;3. Develop and validate a health economic disease simulation model for hepatitis B forIndigenous communities;4: Project clinical outcomes of the Hep B PAST model of care and the status quo up to 2035;5: Assess the cost-effectiveness of introducing the Hep B PAST model of care as standardpractice across the NT.We will develop the first Indigenous-specific health economic model that will be made available to support rapid, robust evaluations to introduce Hep B PAST into other states/territories.
Funding
National Health & Medical Research Council ($750,738)
Scheme
Grant-Ideas
Administered By
University of Tasmania
Research Team
de Graaff B; Cowie Ben; Campbell JA; Wills KE; Stephens N; Palmer AJ
Period
2022 - 2025
Grant Reference
2012285
Lung cancer screening in Tasmania (2022)$24,945
Description
Tasmania has the second highest rate of lung cancer incidence and mortality in Australia. This project will evaluate risk models for identification of high-risk candidates for lung cancer screening and assess whether a screening programme can be effectively and economically implemented. This will lead to earlier identification and treatment, with higher survival rates for Tasmanians, with potential for cost savings.
Funding
Royal Hobart Hospital Research Foundation ($24,945)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Palmer AJ; Harkness N; de Graaff B; Walters EH; Cox IA
Year
2022
Look before you leap: how transthoracic echocardiography before fractured neck of femur saves lives in frail older people. The proposed pragmatic ECHONOF III Trial (2022 - 2026)$3,686,075
Description
For our frail and elderly citizens who fall each year, hip fracture is the frequent result. Urgent surgery offers the best hope of restoring independence and mobility, but it is one of medicine's highest risk procedures. One in 10 patients dies within 30 days, and three in 10 dies within the year. Three in 10 are so frail they must depend on long term nursing home care. Many of these consequences result from underlying cardiac disease, often unknown at the time of surgery. However, pre-surgical focused cardiac ultrasound (FCU) is effective, accurate, and quick in diagnosing heart disease, and does not delay surgery. In our randomised pilot of 100 patients, FCU led to a 39% reduction in a composite outcome of death, acute kidney injury, stroke, myocardial infarction, pulmonary embolism or cardiac arrest at 30 days after surgery. Although FCU is rapidly replacing the stethoscope, there is significant costs of equipment and training required for its widespread use and there is no definitive evidence of improved patient outcome, hence a large pragmatic randomised trial is required. Our group are world leaders in teaching and research in FCU and are the best team to conduct this trial. Ultrasound empowers healthcare professionals to make the best management decisions, potentially transforming patient outcomes and alleviating the vast financial burden of sub-optimal results. The proposed clinical trial of 2000 participants and up to 15 national and international sites, following the same protocol as the pilot. The pilot demonstrated excellent group separation of the primary outcome favouring FCU, good recruitment rate, multicentre collaboration, ease of delivery of the intervention and trial management. This trial is supported by the Australian and New Zealand College of Anaesthetists Clinical Trial Network, and we have sufficient trained staff and equipment at the hospitals, assuring successful completion of this trial.
Funding
Medical Research Future Fund ($3,686,075)
Scheme
Grant - Rare Cancers, Rare Diseases and Unmet Need
Administered By
University of Tasmania
Research Team
Royse C; Canty D; Palmer AJ
Period
2022 - 2026
Prevalence, incidence, risk profiles, and health impacts of residential fires in Tasmania 2010-2020 (2021 - 2022)$30,000
Description
This is the first collaboration between the Tasmanian Fire Service and the Menzies Institute for Medical Research. Using linked data, this project will investigate epidemiological profiles and health services utilisation regarding residential house fires in Tasmania from 2010 to 2020.
Funding
Tasmania Fire Service ($30,000)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Campbell JA; Palmer AJ; de Graaff B
Period
2021 - 2022
Using data linkage to estimate the burden of diabetes in Tasmania (2021)$24,969
Description
Using pathology, hospital, emergency department, and mortality data linked from four different datasets in Tasmania, this project will quantify the health economic burden associated with diabetes for the Tasmanian Health System, and identifying potential factors that may be targeted for improved patient outcomes and/or cost savings to government.
Funding
Royal Hobart Hospital Research Foundation ($24,969)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Palmer AJ; Jose MD; de Graaff B; Campbell JA
Year
2021
NAFLD- screen (Non-alcoholic fatty liver disease: prevalence and screening for type 2 diabetes patients) (2020)$24,999
Description
This study will assess the prevalence of non-alcohol fatty liver disease (NAFLD) in patients with type 2 diabetes and normal liver function tests attending the Royal Hobart Hospital Diabetes Outpatient Clinic. It will further assess the most cost-effective strategy for targeted screening for this patient group.
Funding
Royal Hobart Hospital Research Foundation ($24,999)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
de Graaff B; Yee KC; Campbell JA; Palmer AJ; Lartey ST; McCallum R; Wilson MD
Year
2020
Association between bush fire-smoke/wood-smoke and hospital usage in Tasmania (2020)$10,000
Description
Poor air quality (indoor and outdoor) has been shown to increase morbidity in populations and as a result increase use of health resources. This study will evaluate the association between bush fire-smoke/ wood-smoke and hospital use in Tasmania.
Funding
Royal Hobart Hospital Research Foundation ($10,000)
Scheme
Grant-Incubator
Administered By
University of Tasmania
Research Team
Johnston F; de Graaff B; Palmer AJ; Harkness N; Walters EH
Year
2020
Understanding the economic burden of climate-related extreme events: A framework to support future planning and decision making in the health care sector (2020 - 2021)$57,528
Description
This project blends climate change projection data with health economics to estimate the future health and economic impact of climate-related extreme events in Tasmania. By building on our team's previous research examining the historical impact of heatwaves on Tasmania's health system, this research provides a foundation for policy development and health system planning. Importantly, in addition to specific information on heatwave impacts, this research will provide a generalisable framework to allow the health economic impact of climate change to be estimated for other climate-related natural disasters and compound extreme events. This information can be used by health care services both in Tasmania and across other jurisdictions.
Funding
Department of Premier and Cabinet ($49,528)
Scheme
Climate Research Grants Program
Administered By
University of Tasmania
Research Team
Johnston F; Palmer AJ; Campbell S; Campbell JA; Remenyi TA; Veitch M; McKeown SG
Period
2020 - 2021
The Menzies Multiple Sclerosis Flagship Program (2020 - 2024)$10,000,000
Description
The Menzies Institute for Medical Research Multiple Sclerosis Flagship Program (MS Flagship) leverages the unique critical mass of MS research in Tasmania connected with Australian MS researchers, collaborators, MS societies and people with MS to address the gaps in the assessment, diagnosis and treatment of MS. Our work builds on our well-developed collaborations and laboratory, epidemiological, health economics and clinical research platforms. Our aim is to improve the clinical management of MS by slowing, halting and even reversing the rate of MS disease progression and to improve the quality of life and reduce the impact that MS has on individuals, their families and society. This project will expand the scope of the MS Flagship program and accelerate discoveries in MS research by supporting five key Activities:1.Establish 'MS Stem' - a stem cell bank specifically designed to advance MS research 2.Gain a better understanding of the regeneration of brain cells and myelin repair 3.Expand our understanding of the rare genetic variation underpinning MS using genome sequencing of MS families and 'MS Stem' cell bank samples4.Develop a treatment economic model which can identify cost-effective treatments and interventions for MS 5.Develop education tools and online resources, including an App specifically for people living with MS
Funding
Medical Research Future Fund ($10,000,000)
Scheme
Grant - Accelerated Research
Administered By
University of Tasmania
Research Team
Taylor BVM; Young K; Charlesworth JC; van der Mei IAF; Palmer AJ
Period
2020 - 2024
InforMS - an electronic patient-driven health care model with digital biomarker monitoring that improves the clinical care of people with MS (2020 - 2025)$1,167,815
Description
Multiple Sclerosis (MS) is a high cost and high burden neurological disease.Problem: there are many disease-modifying therapies available, so clinicians can theoretically switch treatments rapidly based on disease activityand side-effects. Yet this proves difficult when data on these is infrequently collected (currently 1-2 times a year) and is insensitive tofluctuations between visits.Solution: modern computing technologies (mobile apps, wearables) are changing the way health is monitored throughout medicine. We areenabled to collect more data, more accurately, and more frequently, and to share it more easily. If we could effectively harness such newmonitoring technologies for MS, clinicians could be supported with objective, prospectively collected, frequently measured, change-sensitivedata.Proposed research: we will create an electronic patient-centred health care system, InforMS, that becomes a one-stop-shop managementsystem for people with MS. It visualises patient-reported data, allows daily tracking and uploading of data from smartphones and wearablesensors, and allows sharing with clinicians via print, email, third-party access and via MSBase: the most widely used clinician registryworldwide. For clinical care, it would (1) enable timelier changes to treatments, and (2) provide greater confidence that treatments work. Forpatient self care, it would (3) empower people with MS to take a central role in managing their disease, and (4) activate them to collect noveltime-sensitive data. For research, it would (5) deliver powerful annual trend data to enhance MS research. This is a paradigm shift in MS careand research.We already have a prototype of InforMS, developed together with end-users. In this proposal, we will add several key functionalities, roll out thefull InforMS system within a registry of ~3,000 people with MS, and follow participants over time to test and optimise the system in practice.
Funding
National Health & Medical Research Council ($767,815)
Scheme
Grant-Partnership Project
Administered By
University of Tasmania
Research Team
van der Mei IAF; Butzkueven H; Taylor BVM; Palmer AJ; Blizzard CL; Nicol D
Period
2020 - 2025
Grant Reference
1193008
SON3599169 Tender - Panel: Health Technology Assessment, Research Support and Other Services (2019)$2,500
Description
The Australian Government Department of Health is seeking to establish a Panel Arrangement of clinical experts and Health Technology Assessment (HTA) groups to provide a range of assessments, review and research support services to the Department. The purpose of HTA is to provide policy-makers, funders, regulators, health professionals and health consumers with the necessary information to understand the benefits and comparative value of health technologies. This information is then used to inform policy, funding and clinical decisions, and assist with consumer decision-making.Prev. external reference ID: Health/18-19/050003
Funding
Department of Health (Cth) ($2,500)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Winzenberg TM; Palmer AJ; Makin JK; Shaw K; Woodhouse P; Polles A
Year
2019
Impact of remoteness on MS outcomes (2019 - 2020)$49,999
Description
*Do people with MS living in regional or remote areas have worse disease outcomes, employment outcomes and quality of life compared to those living in major cities?*How are the costs of MS different for those living in regional or remote areas compared to those living in major cities?*Are any of the above differences explained by personal characteristics (e.g. lower education level), clinical characteristics (e.g. primary progressive onset type), lifestyle characteristics (e.g. lower physical activity level), comorbidities, DMT use, or lack of social support.
Funding
Multiple Sclerosis Australia ($49,999)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Palmer AJ; Taylor BVM
Period
2019 - 2020
PISTACHIO - The Primary Trauma Care Course Impact and Outcome study in Vietnam (2019 - 2020)$150,000
Description
A before and after study in 2 Vietnamese hospitals of the effectiveness of a trauma management course for the reduction of morbidity and mortality of road trauma in that country.
Funding
Elphinstone Group ($150,000)
Scheme
Donation - Individual
Administered By
University of Tasmania
Research Team
Nelson MR; Tran V; Blizzard CL; Skinner MW; Palmer AJ; Tu NH; Thang CQ
Period
2019 - 2020
Evaluation of the Tasmanian Elective Surgery Panel Project (2019)$9,980
Description
In 2015, the Tasmanian State Government allocated additional funds to reduce the public hospital elective surgery waiting lists. A subset of waitlisted patients was 'fast-tracked' for elective surgery to hospitals in Tasmania and Victoria. This project will evaluate the outcomes of this initiative.
Funding
Royal Hobart Hospital Research Foundation ($9,980)
Scheme
Grant-Incubator
Administered By
University of Tasmania
Research Team
de Graaff B; Song J; Hensher M; Campbell JA; Glading JA; Palmer AJ
Year
2019
ANCHOR Project: heAlth ecoNomics and epidemiology of myalgiC encephalomyelitis/ chronic fatigue syndrome (2019 - 2021)$155,000
Funding
Medical Research Future Fund ($155,000)
Scheme
Grant - Targeted Health System and Community
Administered By
University of Tasmania
Research Team
de Graaff B; Campbell JA; Nicholl H; Hensher M; Wills KE; Palmer AJ
Period
2019 - 2021
What is the economic impact of allergic respiratory disease in Tasmania? (2019)$10,000
Description
This project will provide the first economic assessment of the burden of allergic respiratory disease (allergic rhinitis and allergic asthma) in Tasmania. Together, allergic rhinitis and allergic asthma affect over 20% of the Tasmanian population, yet there has been no rigorousanalysis of the health and economic impacts. This project will cost the direct and indirect costs of these conditions across Tasmania. In doing so, we will provide a rigorous evidence base to build a case for allergic respiratory research, and directly inform government and non-government investment in interventions. Our research will be co-designed with expert input from government and non-government stakeholders (Asthma Australia) to ensure alignment with end-user needs.
Funding
University of Tasmania ($10,000)
Scheme
Grant-Research Enhancement Program
Administered By
University of Tasmania
Research Team
Johnston F; Palmer AJ; Jones PJ; Bereznicki BJ; Cooling NB; Zosky GR
Year
2019
The Royal Hobart Hospital's innovative Rapid Access Chest Pain Clinic (RACPC): A health economic evaluation of patient, RHH and community benefits (2019)$24,952
Description
The overall aim of this project is to conduct a comprehensive health economic evaluation of the RHH's cutting-edge Rapid Access Chest Pain Clinic (RACPC) patient care model, compared to the usual care General Cardiology (GCC) clinic model for RHH patients with newly presented chest pain. The RACPC commenced in June 2014 and has realised positive clinical outcomes for its patients. Our comprehensive health economic investigation will build on the clinical work to systematically evaluate the health economic benefits of this innovative model's patient pathways for people who present to the RHH's Emergency Department (approximately 70%) or by referral from a primary care physician (approximately 30%) with new onset chest pain.
Funding
Royal Hobart Hospital Research Foundation ($24,952)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Campbell JA; Black JA; Palmer AJ; Sharman JE; Hensher M; de Graaff B
Year
2019
Lead Support Coordinator Service (LSCS) Evaluation (2018)$99,999
Description
The LSCS trials a new model of coordinated care for clients with complex needs . Three community service organisations, Australian Red Cross, Mission Australia and Baptcare will employ 12 Lead service. Coordinators to provide the service to a maximum of 30 Tasmanians with multiple service needs. Clients will work with the coordinator to identify needs and match them to available services. The evaluation aims to test if this model of coordination leads to better health and wellbeing outcomes for the clients and more efficient and cost effective service delivery.
Funding
Department of Health and Human Services Tasmania ($99,999)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Doherty BT; Nash RE; Elmer SL; de Graaff B; Julian RD; Campbell JA; Palmer AJ
Year
2018
SON3509188 Panel for services relating to health evidence, advice and methods (2018)$10
Description
NHMRC wishes to establish a panel of providers with relevant expertise to assist NHMRC with the development and presentation of evidence based health advice and resources including: a. clinical practice, ethics and public health guidelines; b. systematic reviews and literature reviews; c. public statements; and d. information papers. NHMRC proposes to use the Panel to source providers to support the translation ofresearch into policy and practice according to NHMRC publications development criteria.
Funding
National Health & Medical Research Council ($10)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Winzenberg TM; Makin JK; Palmer AJ; Shaw K; Woodhouse P; Polles A
Year
2018
Reducing the Burden of Liver Cancer for Tasmanians (2018)$350,000
Description
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and is the third leading cause of cancer deaths internationally. It occurs most commonly amongst patients with cirrhosis of the liver, which is often caused by chronic infections with the hepatitis B and/or hepatitis C viruses. The clinical outcomes for patients diagnosed with HCC are highly dependent of the stage at which it is detected. Late detection is associated with significant morbidity and mortality. If detected early, HCC is potentially curable.Screening programs have been suggested to increase the rate of early diagnosis for at-risk groups. In Australia, current guidelines recommend HCC screening for all patients with cirrhosis, regardless of liver disease severity or aetiology. Screening consists of 6-monthly liver ultrasound and alpha-fetoprotein tests. Uptake of screening for HCC is very low in Australia, evidenced by the 5-year survival rate of just 17%. The aims of this project are to a) evaluate current uptake and adherence of HCC screening across Tasmania, b) develop strategies aimed at supporting at-risk patients to participate in regular HCC screening, c) evaluate the cost-effectiveness of screening interventions, and d) assess the effectiveness of new treatments for hepatitis C in reducing the rate of HCC in Tasmania.
Funding
Sefton Bottomley Liver Cancer Bequest ($350,000)
Scheme
Donation - Individual
Administered By
University of Tasmania
Research Team
de Graaff B; Palmer AJ; Yee KC; Cocker FM
Year
2018
Health by Stealth: Increasing Physical Activity through Active Travel in Tasmania (2018 - 2020)$282,362
Description
We are facing a global inactivity crisis. Participation in recommended amounts of physical activity (PA) has remained stagnant since the 1980s,indicating limited population-level impact of strategies to promote PA. A shift in focus from leisure-time to transport-related PA holds promiseas an attractive but under-exploited opportunity to support individuals to incorporate more activity into daily life. Healthy transport options -walking, cycling and public transport - are critical social determinants of health, by reducing traffic accidents, increasing social contact,reducing air pollution, and increasing exercise. Improving our understanding of travel behaviours and identifying strategies to increase use ofhealthy transport options have been identified by our three highly engaged Tasmanian Partner Organisations as important priorities. This projectseeks to generate evidence with service providers, state government and local government authorities to support decision-making and resourceallocation in relation to increasing active and public transport use. Working closely with our Partners, we will analyse data from existing datasources to better understand Tasmanians' travel behaviours and the factors that influence these, by evaluating the effectiveness of two 'realworld'fiscal strategies aiming to increase active and public transport use, and by developing and implementing a knowledge transfer strategy toensure findings are effectively communicated. This project will generate some of the first evidence internationally about the effectiveness offiscal strategies to increase active and public transport use, and will provide crucial information to directly impact the work of service providers,decision makers, policy-makers and practitioners. By identifying effective strategies to increase PA through active transport, the implications of this project have the potential to make major direct health, social, environmental and economic impacts globally.
Funding
National Health & Medical Research Council ($272,362)
Scheme
Grant-Partnership Project
Administered By
University of Tasmania
Research Team
Cleland V; Ball K; Blizzard CL; Greaves S; Jose KA; Palmer AJ; Venn A
Period
2018 - 2020
Grant Reference
1152999
Ambulatory oxygen for interstitial lung disease (2018 - 2022)$1,503,717
Description
Exertional desaturation (low blood oxygen during exercise) is a hallmark of fILD, occurring in over 50% of patients. It is sometimes treated withambulatory oxygen therapy (AOT), which involves breathing supplemental oxygen during physical activity. However the absence of clinicaltrials has given rise to marked variations in policy and practice globally. Even where AOT is available, treatment adherence using the traditionaldelivery method of cylinder gas is extremely poor, as patient burden frequently outweighs any benefit. We have shown that (1) oxygen therapyimproves exercise capacity and markers of skeletal muscle metabolism, suggesting that AOT may impact on physical function, (2) AOT can bedelivered effectively in fILD using a portable oxygen concentrator (POC), which is lighter and more manoeuverable than a cylinder; and (3)POCs are acceptable to patients. We have recently modified a POC to deliver air, providing the effective sham treatment needed for a robustclinical trial.This multi-site randomised controlled trial will determine the clinical benefits and societal costs of AOT for people with fILD and exertionaldesaturation. Our hypotheses are that (1) AOT delivered using a POC will deliver clinically significant improvements in physical activity,symptoms and HRQoL; and (2) AOT delivered using a POC will be cost-effective from a societal perspective. We will conduct a randomisedcontrolled trial with blinding of participants, assessors and clinicians, and an embedded economic evaluation. 260 participants with fILD andexertional desaturation will be randomly assigned to use either AOT or air delivered using a POC for 6 months. If this trial demonstrates clinicaland economic benefits of AOT then the findings can be rapidly translated into practice, with global impact on ILD outcomes and costs.
Funding
National Health & Medical Research Council ($1,503,717)
Scheme
Grant-Project
Administered By
Monash University
Research Team
Holland A; McDonald C; Corte T; Chambers D; Palmer AJ; Ekstrom M; Glaspole I; Goh N; Hepworth G
Period
2018 - 2022
Grant Reference
1139953
The value of osteoporosis interventions evaluating the cost effectiveness and incorporating patients preference (2018 - 2021)$322,952
Description
The value of osteoporosis interventions: evaluating the cost-effectiveness and incorporating patients' preference
Funding
National Health & Medical Research Council ($322,952)
Scheme
Fellowship-Early Career
Administered By
University of Tasmania
Research Team
Si L; Palmer AJ
Period
2018 - 2021
Grant Reference
1139826
Economic Impact of MS - 2007 cost of illness data AMSLS - PPMS sub-analysis (2017)$49,379
Description
Based on the published report 'Economic Impact of Multiple Sclerosis in 2010 - Australian MS Longitudinal Study (AMSLS)' Roche is interested in cost and utility data collected from patients with primary progressive multiple sclerosis (PPMS) only.Despite the type of MS not specifically being captured in the 2007 Cost Diary, 39 people with PPMS could be identified by matching participants with a more recent data collection.Roche is seeking Australian, PPMS-specific cost and utility data to inform a PBAC submission lodged in March 2017. A sub-analysis of the data presented in the 2010 report for PPMS patients only was identified as a viable data source to inform the PBAC submission. Objective*PPMS-specific cost and utility data from the 2010 AMSLS analysis (2007 Cost Diary) categorised for applicability in a PBAC submission.*Cost and utility data reported per EDSS*Results available six weeks from the date of the fully signed contract.
Funding
Roche Products Pty Ltd ($49,379)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Palmer AJ; Taylor BVM
Year
2017
Economic Impact of MS in Australia Report (2018) (2017 - 2018)$169,000
Description
*Study to estimate the prevalence of MS in Australia;*Data entry and data cleaning of 2016 AMSLS Cost Diaries;*Analysis of the cost of illness data based on the AMSLS economic impact baseline surveys and cost diaries - the analysis will include both direct and indirect costs of MS.*An analysis of impact on utility/quality of life;*Comparison of results with the 2005 and 2011 Economic Impact reports;*Production of a final presentation Report to include:1.An overview of MS2.Prevalence of MS3.Healthcare costs and indirect costs (including lost productivity)4.Quality of life for those affected by MSProject to be conducted and completed with reference to and in accordance with the 2017 Economic Impact Report Terms of Reference and Merck Grant agreement with MS Research Australia
Funding
Multiple Sclerosis Australia ($169,000)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Palmer AJ; Taylor BVM
Period
2017 - 2018
AusGo-SHEMO..Let's Go! Australian Gold Standard Health Economics Model of Osteoporosis (2017 - 2019)$393,987
Description
We will develop an unbiased, gold standard, validated, transparent health economics model of osteoporosis to identify cost-effective screeningand treatment strategies, and that will be made widely available to all stakeholders. Without this model, scarce health care resources may besquandered on osteoporosis screening strategies and osteoporosis-related fracture prevention medications that are not cost-effective. Worse,patient access to cost-effective medications may be delayed.
Funding
National Health & Medical Research Council ($393,987)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Palmer AJ; Eisman JA; Si L; Winzenberg TM; Sanders K; Center J
Period
2017 - 2019
Grant Reference
1127827
Centre of Research Excellence in Pulmonary Fibrosis (2017 - 2022)$2,498,606
Description
The Centre for Research excellence in Pulmonary Fibrosis (CRE-PF) aims to develop a sustainable nation-wide network, consisting of world recognized experts. The group will enable an integrative approach to solving PF through a layered strategy extending from molecules germane to disease pathogenesis, to human studies. With this approach the CRE-PF will set a new paradigm for synergy between academia, health care, health policy and the public, placing Australia at the forefront of innovation.
Funding
National Health & Medical Research Council ($2,498,606)
Scheme
Grant-Centre of Research Excellence
Administered By
University of Sydney
Research Team
Corte T; Knight D; Laurent GJ; Holland A; Chambers D; Moodley Y; Walters EH; Westall G; Glaspole I; Palmer AJ
Period
2017 - 2022
Grant Reference
1116371
Sustained Effective Oral Care to Significantly Reduce Aspiration Pneumonia experienced by Adults with Dementia in Residential Care (2016 - 2017)$99,572
Description
Oral care is critical to keeping the mouth clean and the body and brain as healthy as possible. This is especially the case for adults with dementia who rely on others for care. With poor oral health, harmful bacteria throughout the mouth cause tooth decay, gum inflammation, gum disease, and tooth loss. Frequently adults with dementia take multiple medications and the side-effects of these medications include reducing saliva and drying the mouth which in turn increase the harmful oral bacteria. When these harmful bacteria are breathed (or aspirated) into the lungs, the lungs become infected and aspiration pneumonia results. Adults with dementia, particularly those who live in residential communities, are vulnerable to aspiration pneumonia as they are often frail, not well nourished, have complicating medical conditions such as diabetes, heart disease, lung disease, and swallowing problems, as well as needing help from others for their care. We know, from published studies, that vulnerable adults who have their own teeth need to brush their teeth for 2 minutes after each meal. Adults who wear dentures need to clean their dentures each day and take them out when they are planning to sleep. Whether they have their own teeth or wear dentures, all adults with dementia also need to rinse their mouth after each meal. Unfortunately, oral care for adults with dementia in residential communities remains inconsistent and fragmentary. Our studies have documented the barriers, real and perceived, that prevent systematic oral care and we have developed a protocol to overcome these barriers. This protocol has five components: (1) establishment of an innovative Community of Practice (CoP) including health care professionals in the community-at-large, policy-makers, and consumers, together with visionary residential care leaders and nurse-carer champion partners to support staff and drive practice change; (2) education of nurse-carer champions by CoP members; (3) ongoing education and training of all point-of-care staff by nurse-carer champions as they work with RACF-based dental/oral health therapy students, and are supported by CoP members and online resources; (4) implementation of daily evidence-based oral care by staff; and (5) regular audits of daily oral care by nurse-carer champions and the students to ensure its sustained implementation.To measure the effectiveness of our protocol, we will follow 60 residents in each of two residential care communities in Tasmania. We will document the number of cases of aspiration pneumonia these residents experience before and after a 3-month period of daily evidence-based oral care (component 4 of the protocol). We also will document the number of times these residents have been transferred to hospital or admitted to hospital before and after the 3-month period of daily oral care. To document improvements in the residents' oral, nutritional and general health and their quality-of-life (QOL), we will use the following measures that are appropriate for adults with dementia: (i) Oral Health Assessment Tool (OHAT), (ii) Mini-Nutritional Assessment (MNA), (iii) 3-day food record, (iv) Yale Swallow Protocol that identifies any signs of swallowing difficulty, (v) Sit-to-Stand Manoeuvre that identifies any difficulties with strength and movement, and (vi) the EuroQol-5 dimension tool that documents residents' perceptions of their ability to move, care for themselves, and participate in daily activities along with any pain, discomfort or anxiety they are experiencing. We will administer these measures to the residents before and after the 3-month period of evidence-based daily oral care. We will analyse the data and write reports about the findings. We will publish these reports in academic journals and magazines that are widely-read by the public. We will network with social media outlets (radio, television, and Facebook sites) and policy-makers to share our findings as widely as possible. We antic
Funding
Dementia Collaborative Research Centre ($99,572)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Goldberg LR; Crocombe LA; Robinson AL; Lea EJ; Breen JL; Palmer AJ; McInerney F; Jones I; Beattie E; Toye C; Brennan DS; Heiss C
Period
2016 - 2017
Comparison of learning focused cardiac ultrasound between self-directed/simulator and instructor/live model teaching (2016)$32,000
Description
Our proposed project aims to test whether our new self-directed learning simulator course is as effective as the current standard teaching model that uses lots of instructors and human volunteer models. The advantages of the simulator course include reduced reliance on instructors, increased availability of the course (ability to train a lot more doctors than the current standard course) to and the ability to also teach learning of diagnosis of heart disease (not possible with the current human model). A health economic analysis will also be performed to determine if the new simulator course is as cost-effective (economical) as versus the traditional course. If the new course is as effective and economical as the current course then the simulator course may become the new method for teaching bedside ultrasound as it has important advantages over the traditional method such as increased accessibility and capacity to train doctors, and the ability to teach how to diagnose heart conditions. This would result in significant health benefits to a very large number of patients worldwide.
Funding
Australian and New Zealand College of Anaesthetists ($32,000)
Scheme
Grant - Project Grant Funding
Administered By
University of Tasmania
Research Team
Canty DJ; Royse A; Royse C; Palmer AJ
Year
2016
Does treating multiple sclerosis alter long-term disease outcomes? a natural history study (2016 - 2017)$180,000
Description
A natural history study of MS outcomes between a treated (Australian) versus untreated NZ population to study the long-term effects of MS disease modifying drugs. This is a clinical epidemiological project.
Funding
Multiple Sclerosis Australia ($180,000)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Taylor BVM; van der Mei IAF; Palmer AJ; Blizzard CL; Butzkueven H; Simpson Jr S; Kalincik T; Carroll W; Mason D
Period
2016 - 2017
Evaluation of new Tasmanian general practice after hours incentive funding model and the value for money of GP Assist (2015 - 2016)$159,970
Description
This project will encompass an evaluation of the after-hours incentive funding model and the 'value-for-money' of the GP Assist after-hours telephone support service. This research project will: a) conduct and survey of Residential Aged Care Facilities pre- and post- implementation of the new funding model and a survey of general practices post-implementation of the funding model; b) provide an analysis of existing data collections on clinic hours and MBF billings data; c) deliver a final report based on the evaluation of the collected data, providing recommendations on the feasibility and ongoing sustainability of the model.
Funding
Primary Health Tasmania ($159,970)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Neil A; Nelson MR; Palmer AJ; Sanderson K
Period
2015 - 2016
GP Assist Evaluation (2015 - 2017)$41,335
Description
The University has been engaged by a third party Primary Health Tasmania to undertake collaborative research in relation to its funding of the GP Assist program and establishing whether it is adding value to the after-hours provision of general practice services to residential aged care facilities, palliative care services and the Tasmanian community (Third Party Services). The Crown is engaging the University under this Agreement to conduct additional research as part of the University undertaking the Third Party Services to determine whether the Crown's funding of GP Assist to further assess the GP Assist's contribution (if any) to the efficiency and sustainability of the rural health services.
Funding
Department of Health and Human Services Tasmania ($31,335); Tasmanian Health Service - Southern Region ($10,000)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Neil A; Nelson MR; Palmer AJ; Sanderson K
Period
2015 - 2017
DEVA MS: DEvelopment and VAlidation of a cost effectiveness simulation model for Multiple Sclerosis and implications for health policy (2015 - 2016)$160,000
Description
The number of people with multiple sclerosis (MS) is increasing dramatically in Australia, with rapidly escalating associated costs, both direct due to medical expenses and indirect due to lost or reduced employment. Existing and upcoming treatments for MS are expensive, with current prices of up to $25,000 per patient per year and rising. Using the best available data, this study will identify the treatments that are greatest value for money for the most common form of MS (relapsing-remitting MS), with a goal to reduce wastage of limited healthcare resources.
Funding
Multiple Sclerosis Australia ($160,000)
Scheme
Grant-Project
Administered By
University of Tasmania
Research Team
Palmer AJ; Taylor BVM; van der Mei IAF; Clarke P; Simpson Jr S
Period
2015 - 2016
Provision of Health Economics consultancy service to develop a new Tasmanian GP After Hours Incentive Funding Model(s) (2014)$79,822
Description
This project will develop a series of increasingly redistributive funding models supporting the provision of accessible and effective after hours care throughout Tasmanian that address core objectives and identified areas of concern.
Funding
Primary Health Tasmania ($79,822)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Neil A; Palmer AJ; Nelson MR
Year
2014
Australian MS Longitudinal study (2014 - 2024)$1,372,869
Description
The main objectives of this project are: a) to continue the established multi-disciplinary research database for Australia with MS that will provide answers to important questions about the disease that are not able to be addressed by projects funded in the normal, relatively short cycle of research grants; b) to encourage nationwide (and international) multi-disciplinary collaboration on MS research projects, utilising valid and reliable measures that are internationally accepted and compatible wherever possible, and to lead by example in the unification of Australia's efforts to solve the various problems associated with MS; c) to reduce the cost of multi-disciplinary research on MS by provision of a large, well-characterised cohort of volunteer subjects for future studies.
Funding
Multiple Sclerosis Australia ($1,372,869)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
van der Mei IAF; Taylor BVM; Palmer AJ
Period
2014 - 2024
Dementia-related presentations at the Royal Hobart Hospital - A pilot program for redesigning state-wide clinical care pathways involving Tasmanian residential aged care facilities (RACFs) and their c (2014)$6,873
Description
This project explores dementia-related presentations to the RHH to inform the development of new clinical pathways to reduce preventable and unplanned hospital transfers that are costly and have poor outcomes for people with dementia. Care pathways from RACFs and community settings to the RHH will be reviewed.
Funding
Royal Hobart Hospital Research Foundation ($6,873)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Annear MJ; Nicols H; Powell D; Bell EJ; Elliott KJ; Palmer AJ; Vickers JC; Eccleston CEA; McInerney F
Year
2014
Improving prevention and early intervention for type 2 diabetes in Tasmania (2014)$54,673
Description
This project will use the AUSDRISK tool in a random mail-out to seniors card holders and via clinical contact at Clarence ICC (to increase the numbers of adults assessed in healthcare settings). Training will be provided for optomeyes and Clarence ICC personnel in the use of the tool. Follow up will be conducted with respondents who scored as being high risk, including recommended management by both the individual and their GP.
Funding
University of Tasmania ($54,673)
Scheme
null
Administered By
University of Tasmania
Research Team
Macintyre K; Burgess JR; Palmer AJ; Shaw K; Bingham L
Year
2014
Clinical Redesign of respiratory pathways in residential aged care (2014)$80,000
Description
Respiratory conditions are a leading cause of unplanned admissions from residential aged care and the wider community. This project aims to reduce the burden of preventable unplanned admissions from aged care facilities and improve health outcomes.
Funding
University of Tasmania ($80,000)
Scheme
null
Administered By
University of Tasmania
Research Team
Bell EJ; Robinson AL; Walters EH; Palmer AJ; Winter RE; Annear MJ; Elliott KJ
Year
2014
Bariatric surgery in Tasmania: investigating health service use, costs, patient outcomes and policy options (2014 - 2019)$839,027
Description
About 1 in 20 Tasmanians are severely obese. Bariatric surgery can improve health for individuals with severe obesity but access to surgery is poor for most public patients. This study will investigate the pathways of patients referred for bariatric surgery in the Tasmanian public and private hospital systems to better understand the demand for surgery, the health outcomes, and costs associated with these different pathways. The findings will inform public policy and resource allocation.
Funding
National Health & Medical Research Council ($644,027)
Collaborators
Department of Health and Human Services Tasmania ($150,000); Department of Premier and Cabinet ($45,000)
Scheme
Grant-Partnership Project
Administered By
University of Tasmania
Research Team
Venn A; Palmer AJ; Ezzy D; Blizzard CL; Nelson MR; Neil A
Period
2014 - 2019
Grant Reference
1076899
Bariatric surgery in Tasmanian public hospitals: investigating health service use, costs, and policy options (2014)$8,088
Description
Bariatric surgery is considered an effective treatment for significant obesity-related illness but it is difficult to access in Australian public hospitals. By describing Tasmanian public patients' characteristics, clinical pathways, costs and outcomes this project will support better informed decision-making about Tasmanian public hospital services for clinically obese patients.
Funding
Royal Hobart Hospital Research Foundation ($8,088)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Venn A; Wilkinson S; Greenaway T; Hensher M; Palmer AJ; Blizzard CL; Neil A
Year
2014
Guidance of Heart Failure Management Programs by Risk Assessment (2013 - 2018)$1,422,739
Description
The aims of this project are to reduce Heart Failure (HF) admissions and costs in Tasmania by: i) using data linkage to identify locations where community service delivery should be targeted, and to evaluate current performance in HF readmission across the State; ii) developing a risk algorithm for HF readmission, including psychosocial determinants; iii) using i) and ii) devising a novel means of providing a disease management program (DMP), titrated to risk assessment, with physiologic assessment used to guide the management of the highest risk patients; iv) developing a clinical trial to define the merits of this approach; v) evaluating the cost-effectiveness of this intervention; vi) presentation of educational activities with community-based providers. A successful intervention is likely to be sustainable. As HF readmissions in Tasmania cost ~4550 bed days/y, the investment in this grant (~$1/2m/y) could be reproduced by a 50% reduction of readmissions.
Funding
National Health & Medical Research Council ($942,739)
Scheme
Grant-Partnership Project
Administered By
University of Tasmania
Research Team
Marwick TH; Venn A; Sanderson K; Nelson MR; Palmer AJ; Blizzard CL
Period
2013 - 2018
Grant Reference
1059738
Improving care through imbedding general practitioners within residential aged care facilities (2013 - 2015)$404,875
Funding
Bupa Foundation (Australia) Limited ($404,875)
Scheme
Grant-Expression of Interest Grants Program
Administered By
University of Tasmania
Research Team
Robinson AL; Haines T; Palmer AJ; Vickers JC
Period
2013 - 2015
Development and validation of a health policy simulation model for type 1 diabetes (2012 - 2014)$336,549
Funding
National Health & Medical Research Council ($336,549)
Scheme
Grant-Project
Administered By
University of Melbourne
Research Team
Clarke P; Palmer AJ; Milne G; Briggs A; Herman W; Eliasson B
Period
2012 - 2014
Grant Reference
1028335
Epidemiology and economic impact of injuries to jockeys in the thoroughbred racing industry (2011 - 2012)$50,855
Funding
WorkCover Tasmania ($50,855)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Palmer AJ; Hitchens PL
Period
2011 - 2012
5th Mount Hood Challenge Conference Malmo Sweden 18-19 Sept 2011 (2010)$14,018
Funding
Janssen-Cilag Pty Ltd ($14,018)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Palmer AJ
Year
2010
Improving health and wellbeing in the Tasmanian State Service workforce (2010 - 2014)$916,250
Funding
National Health & Medical Research Council ($856,250)
Scheme
Grant-Partnership Project
Administered By
University of Tasmania
Research Team
Venn A; Sanderson K; Blizzard CL; Taylor R; Wood-Baker R; Palmer AJ; Nelson MR; Turner P
Period
2010 - 2014
Grant Reference
544954

Research Supervision

Current

3

Completed

21

Current

DegreeTitleCommenced
PhDBurden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Australia2020
PhDEconomics of the Primary Trauma Care Course2024
PhDInterstitial Lung Disease: Health economics2024

Completed

DegreeTitleCompleted
PhDFactors Influencing Patient Outcomes in Idiopathic Pulmonary Fibrosis in Australia
Candidate: Qiang Zheng		2023
PhDImpact and Correlates of Early Knee Osteoarthritis
Candidate: Ambrish Singh		2023
PhDUsing Data Linkage to Estimate the Burden of Diabetes in Tasmania
Candidate: Thi Thu Ngan Dinh		2023
PhDAssessing the Health Burden of Bushfire Smoke in Australia
Candidate: Nicolas Borchers Arriagada		2022
PhDHealth Economics Aspects of Primary Liver Cancer in Australia
Candidate: Anh Le Tuan Nguyen		2022
PhDAssessing the Burden and Economic Impact of Idiopathic Pulmonary Fibrosis in Australia
Candidate: Ingrid Adamina Eve Cox		2022
PhDHealth Economics of Bariatric Surgery
Candidate: Qing Xia		2022
PhDHealth System Sustainability: New perspectives from macroeconomics and ecological economics
Candidate: Martin Christopher Hensher		2022
PhDInvestigating the Evolution of Model-based Health Economic Evaluations and Changes in Health-related Quality of Life in Osteoarthritis
Candidate: Ting Zhao		2021
MastersThe Demographic and Clinical Characteristics of Primary Liver Cancer Patients in Tasmania
Candidate: Thi Thu Hoa Nguyen		2021
PhDHealth-Economic Consequences of Multiple Sclerosis in Australia
Candidate: Hasnat Ahmad		2021
PhDUnderstanding the Prevalence and Impact of Comorbidities on People with Multiple Sclerosis
Candidate: Lara Marie Pangan Lo		2021
PhDThe Health Economics of Obesity in Adult Populations in Ghana
Candidate: Stella Twumwaa Lartey		2020
PhDImproving Employment Outcomes for People with Multiple Sclerosis
Candidate: Jing Chen		2020
PhDPublic Bariatric Surgery in Tasmania: Patient pathways and health service use
Candidate: Alexandr Kuzminov		2019
PhDThe Health Economics of Obesity and Bariatric Surgery
Candidate: Julie Anne Campbell		2018
PhDThe Health and Economic Burden of Multimorbidity in Australia
Candidate: Lili Wang		2017
PhDBariatric surgery: Pathways, perspectives and policy options
Candidate: Melanie Jayne Sharman		2017
PhDThe Health Economics of Haemochromatosis
Candidate: Barbara de Graaff		2016
PhDHealth Economics in Osteoporosis: Construction and application of a new state-transition microsimulation model
Candidate: Lei Si		2016
PhDHealthy, wealthy and wise. Investigating the application of health economics in workplace health promotion: the economic evaluation of Healthy@Work
Candidate: Siyan Baxter		2015